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CHAPTER I
INTRODUCTION

Peripheral nerve injuries constitute a large portion of neurotrauma seen in clinical
settings and are associated with limb damage, skeletal fractures, and surgical
interventions made to correct other medical problems. Though peripheral motoneurons
are capable of regeneration following axonal injury, suboptimal functional outcomes
usually follow from such damage in clinical situations. These suboptimal outcomes
negatively impact patients’ quality of life, examples of which include the impairment of
emotional expression after facial nerve paralysis, the difficulties in properly intoning
speech following recurrent laryngeal nerve paralysis, and the altered stance and gait
patients experience following paralysis of nerves innervating the leg. Animal and in vitro
models that mimic the types of peripheral nerve injuries seen clinically need to be
developed so that therapies, those in use as well as potential ones, can be evaluated sideby-side. Our laboratory has developed both extratemporal and intratemporal facial nerve
crush models and has extensively explored the effects of treatments including the gonadal
steroid testosterone and electrical stimulation, as well as their combination. Emerging
from these studies is the idea that there are distinct post-injury stages of cellular repair
that occur, and these stages can be augmented by a combinatorial treatment strategy to
promote repair and increase functional recovery. The combinatorial therapy of
1
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testosterone and electrical stimulation has been shown to be beneficial in two models of
facial nerve injury; however, it is unknown whether this benefit applies in other
peripheral nerve injury situations. This dissertation intends to develop distinct clinically
relevant peripheral nerve injury models in order to investigate the generality of the effects
of a combinatorial treatment consisting of testosterone and electrical stimulation on
functional recovery from peripheral nerve injury.

Aim 1: Determine the effects of the combination of brief ES and TP on functional
recovery following intracranial facial nerve crush in rats. The working hypothesis is
that administration of the combination treatment consisting of TP and brief ES soon after
injury shortens recovery time after an intracranial facial nerve crush. Immediately
following an intracranial crush, gonadectomized adult male rats will receive implants of
empty or TP-filled capsules and/or a one-time ES treatment 30min in duration or sham
stimulation. Daily facial functional recovery and weekly motor nerve conduction will be
assessed up to 12 weeks post-operative and will be compared between the different
treatment groups (No TP/No ES and TP+ES).
Aim 2: Determine the effects of brief ES and/or TP on functional recovery following
recurrent laryngeal nerve crush axotomy in rats. The working hypothesis is that the
administration of TP and brief ES soon after injury shortens recovery time after
recurrent laryngeal nerve crush.

Gonadectomized adult male rats will undergo left

recurrent laryngeal nerve crush axotomies, will receive empty or TP-filled capsule
implants, and will receive a one-time ES treatment for 30min or sham-stimulation. The
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rats will be divided into 4 treatment groups: 1) No TP/No ES, 2) TP-only, 3) ES-only,
and 4) TP+ES. For each group, direct laryngoscopy will be used to compare vocal fold
mobility between the different treatment groups at 1, 2, 3, 4, 5, and 6 weeks postoperative.
Aim 3: Compare the effects of the combination treatment of brief ES and TP on
functional recovery following both a sciatic nerve crush as compared to a sciatic
nerve transection-surgical repair (autograft) injury in rats. The working hypothesis
is that the combination treatment of brief ES and TP will shorten recovery time after a
crush injury to the sciatic nerve in a similar manner to that of an autograft injury of the
sciatic nerve. Gonadectomized adult male rats trained to run on the CatWalk apparatus
(Noldus) will undergo either a right sciatic crush or a right sciatic nerve transection with
autograft repair at the level of the mid-thigh. Immediately afterward, rats will receive
implants of TP-filled or empty capsules and/or a one-time ES treatment of 30min, and
will be divided into the same 2 treatment groups as in aim 1. The CatWalk apparatus will
be used weekly to compare gait changes between the different treatment groups, and
assessments will be done at 2, 4, 8, and 16 weeks post-operative.

CHAPTER II
LITERATURE REVIEW

A. INTRODUCTION
The nervous system is divided into two parts; the central nervous system (CNS)
consists of the brain and the spinal cord and the peripheral nervous system (PNS) consists
of all of the remaining nervous tissue throughout the body. The functional unit of the
PNS, the peripheral nerve, is commonly damaged during bodily trauma and can be
damaged during surgery; often the final result is substandard recovery from the nerve
injury. Though neurons in the PNS are capable of regenerating their injured axons,
recovery is dependent on the amount of neuronal cell loss, regeneration rate, and
successful target reinnervation. Currently no treatment regimen exists that reliably
promotes regeneration following peripheral nerve trauma.
Three peripheral nerves are frequently injured in humans and can thus be used to
design and test treatment strategies that enhance regeneration. These nerves are the facial
nerve, the recurrent laryngeal nerve, and the sciatic nerve. The facial nerve has a complex
anatomical course from the brainstem to the muscles it innervates. Recovery from facial
nerve paralysis is dependent on the site of injury and so development of different animal
models representing these different injury sites will be beneficial to both determine the
degree of regeneration and to examine the effects of potential treatments. The recurrent
laryngeal nerve, a branch of the Vagus nerve, also maintains a complicated course as its
4
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axons journey from the brainstem through the neck and thorax and wind up back in the
neck to innervate muscles in the larynx. This complicated course makes the nerve
vulnerable to injury during neck surgeries and presents an ideal opportunity to examine
the effects of potential treatments. The sciatic nerve is the largest nerve in the body and
the consequences of its injury are debilitating, making it a prime target to test the
recovery potential of new therapies.
Gonadal steroids and electrical stimulation (ES) are two interventions that have
the potential to be translated to the clinic. Previous work indicates that their combination
enhances axonal regeneration and improves functional recovery; however, since this has
only been investigated in facial nerve injury paradigms it still remains to be seen if this
combination therapy is widely applicable to peripheral nerve injury in general.

B. PERIPHERAL NERVOUS SYSTEM INJURY
Whereas the mature central nervous system (CNS) usually does not regenerate
after injury, the peripheral nervous system (PNS) has the advantage of a permissive
environment in concert with the activation of its intrinsic growth capacity which aids
regeneration (Vargas and Barres, 2007). Despite this regenerative potential, functional
recovery following peripheral nerve injury is often suboptimal. Recovery outcome is
variable and depends on a multitude of factors: the proximity of lesion to the cell body,
regeneration distance to target, and age of patient (Fu and Gordon, 1995a; Fu and
Gordon, 1995b; Birch and Raji, 1991; White and Vaughan, 1991; Vaughan, 1992).
Peripheral nerves are surrounded with fatty cushioning at locations that are vulnerable to
mechanical perturbations, but they are still frequently damaged by physical insults. Such
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insults include disruption of the myelin sheath causing conduction blocks or severe
forces that crush, stretch, or sever the nerve.

1. ANATOMY OF A PERIPHERAL NERVE
The epineurium is the outer sheath of an entire peripheral nerve; it consists of
condensed layers of connective tissue made of collagens (Sunderland, 1991; Lee and
Wolfe, 2000). Each peripheral nerve trunk is composed of multiple bundles or fascicles
of nerve fibers. As the epineurium encircles and runs between fascicles, its main function
is to sustain and protect them. Each nerve fascicle is surrounded by a well-defined sheath
known as the perineurium; it contributes to nerve tensile strength. Within the fascicles,
each individual axon and its Schwann cells are surrounded by the endoneurium and
endoneurial fluid, a low-protein fluid that is the correlate of cerebrospinal fluid to the
peripheral nervous system (Sunderland, 1991). The endoneurium functions to cushion
and nourish the individual axons.
A network of blood vessels supplies blood to a peripheral nerve. Of the two
major arterial systems, one lies superficially on the nerve and the other lies within the
interfascicular epineurium; the two are connected via anastomoses to a minor
longitudinal system (Sunderland, 1991). The endoneurial capillaries act as an extension
of the blood-brain barrier; the tight junctions between the endothelial cells create a
system impermeable to a wide range of constituents and serve to separate the endoneurial
fluid from the blood. Injury, ischemia, or toxins can disrupt this barrier.
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2. INJURY CLASSIFICATIONS
In 1943, Seddon grouped nerve injuries into three major classifications in
increasing severity: neurapraxia, axonotmesis, and neurotmesis. Neurapraxia is defined
by local myelin damage which usually results from nerve compression. Axonotmesis is a
loss of continuity of axons, with variable damage of the endoneurial and perineurial
sheaths; however, the epineurium is intact. Finally, neurotmesis is characterized by a
disruption of the epineurial sheath and the complete physiologic perturbation of the entire
nerve trunk, such as in a complete transection injury (Seddon, 1943). After injury,
functional losses occur in the following sequence: motor, propioception, touch,
temperature, pain, and sympathetic (Lee and Wolfe, 2000). Recovery usually occurs in
the reverse order and incomplete injuries are more frequent than complete separation.
Furthermore, mixed nerve injuries, in which all fibers are affected but to varying degrees,
are fairly common.

3. CLINICAL PICURE: COMMON PERIPHERAL NERVE INJURIES
The facial, recurrent laryngeal, and sciatic nerves are three commonly injured
nerves which often lead to unsatisfactory or delayed recovery and thus serve as targets for
new therapeutic interventions. Though they are disparate and in completely separate
parts of the body, a common thread that binds them is that injury to each yields
noticeable functional deficits.
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a. Facial Nerve Injury
As the most commonly injured cranial nerve, lesions of the facial nerve occur at
an incidence of ~30 cases per 100,000 (Gilden, 2004). Not only do such lesions result in
noticeable distortion of the face, but other complications can occur.

The eyelid droop

characteristic of facial nerve palsy is due to the paralysis of the temporalis muscle; the
temporalis muscle is then unable to raise the eyebrow and subsequently pushes the eyelid
tissue down over the eye. Though the eyelid itself can open because cranial nerve III
controls the levator palpebrae superioris muscle, it has difficulty closing because the
orbicularis oculi is responsible for closing the eyelid and is innervated by the facial nerve.
This increases exposure of the eye and can result in dry eye, infections, and in severe
cases, corneal ulcers and loss of the eye from perforation (Kerrebijn and Freeman, 1998).
Other complications can include drooling, speech difficulties, and inability to retain
airway patency (Rosson and Redett, 2008). Another common complication in patients
with facial nerve injury is synkinesis, or the involuntary movement of part of the face
during the voluntary movement of another part of the face. (Kiese-Himmel et al., 1993;
Mavrikakis, 2008).

i. Anatomy & Etiology
The facial nerve is particularly susceptible to injury because of its elaborate
anatomical course from the brainstem to the muscles it innervates. The three main
segments of the facial nerve are intracranial, intratemporal, and extratemporal. The
intracranial segment of the nerve arises near the pons, travels within the cerebellopontine
angle and enters the temporal bone through the internal auditory meatus (Figure 1). After
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Figure 1: Course of the Facial Nerve. Upon exit from the facial nucleus, the facial nerve runs
intracranially, then enters the internal auditory meatus (IAM), turns in the facial canal, and exits the
mastoid bone at the stylomastoid foramen (SMF). Different types of injuries can occur at different
segments of the nerve: 1) extratemporal 2) intratemporal and 3) intracranial. CPA (cerebellopontine
angle).
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entering the temporal bone, it is confined within a prolonged canal, which is often not
much greater in diameter than the nerve itself (intratemporal segment). The nerve exits
the skull at the stylomastoid foramen (SMF) and from thenceforth is termed
extratemporal; it then travels through the parotid gland in its course towards the facial
muscles. After branching into five main divisions and many smaller divisions, it exits the
parotid gland to finally reach its targets. The course of the facial nerve through the
posterior fossa, temporal bone, and parotid gland renders it vulnerable to many
neoplastic, traumatic, and infectious events.
Lesions of the facial nerve within the cerebellopontine angle and the internal
auditory meatus are usually due to compression by acoustic neuromas, meningiomas, or
tumors of the jugular vein (Mavrikakis, 2008; Rosson and Redett, 2008).

Surgical

removal of these neoplasms can pose additional damage to the nerve. Lesions of the
facial nerve within the temporal bone are due to Bell’s palsy, skull fractures, spread of
inner ear infections, and petrous-temporal cancer. Bell’s palsy is the most common
sudden cause of facial nerve paralysis and is believed to result from inflammation of the
facial nerve during its course in the temporal bone due to reactivation of herpes simplex
virus-1, leading to compression and possibly ischemia and demyelination (Tiemstra and
Khatkhate, 2007). Extratemporal injuries of the facial nerve may result from traumatic
injuries (lacerations and gunshot wounds) and complications arising from the removal of
parotid gland tumors.
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ii. Evaluation & Management
The House-Brackmann grading scale is the gold standard for grading facial nerve
function (House and Brackmann, 1985). This system relies on evaluation of symmetry of
the face during rest, degree of voluntary movement on the affected side, and degree of
synkinesis, with scores assigned from 1-6 in increasing severity of dysfunction. The
degree of nerve damage is often also assessed by nerve conduction studies. A reduction
in the compound muscle action potential suggests axonal degeneration has occurred, and
an increase in latency indicates the nerve has suffered demyelination (Kimura, 2006).
Several medical and surgical interventions are currently used for facial nerve
injuries. Incomplete paralysis has an excellent prognosis and is managed purely by
observation (Danner, 2008).

Following complete facial nerve paralysis, the use of

corticosteroids is suggested to minimize nerve edema and degradation in nerve function.
Whether corticosteroids should be administered, however, is still controversial, as their
efficacy has not been clearly demonstrated (Turk-Boru et al., 2005). The administration
of corticosteroids to rats with experimental intratemporal facial nerve injury does not
provide added benefit to other treatments studied (Sharma et al., 2010a); hence, the side
effects of exogenous corticosteroids may outweigh the benefits.

Current surgical

interventions include decompression, anastomoses, and nerve grafting. Decompression
involves removing bone to relieve pressure on the nerve from its surroundings. When the
facial nerve is transected or sufficiently injured, requiring the injured portion to be
removed, an end-to-end anastomosis (repair with suture or glue) is performed (Danner,
2008). When additional nerve length is needed, a cable nerve graft is used. Even though
these surgeries re-establish connection between the ends of the facial nerve, regeneration
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of axons across the reapposition site may be hindered. Therefore, the need to develop
better treatments prevails as suboptimal functional recovery is often seen.

b. Recurrent Laryngeal Nerve (RLN) Injury
Recurrent laryngeal nerve lesions result in significant patient morbidity, causing
vocal fold paralysis and incomplete glottic closure which can lead to changes in vocal
pitch or a lack of voice, dysphonia, dysphagia, and in some cases aspiration (Araki et al.,
2005; Tessema et al., 2009). The effects of these symptoms on patient quality of life can
be devastating and recovery from this type of injury is variable as well as dependent on
the degree of the initial damage; some patients recovery spontaneously within weeks
while others never do (Myssiorek, 2004; Rosenthal et al., 2007). Changes in vocal pitch
and quality, when accompanied with increased vocal effort, are particularly difficult to
deal with for patients because the voice, like one’s face, is a distinguishing characteristic
separate to each individual. A patient with a radial nerve injury experiences loss of
function of a part of her body of which she possesses, whereas a patient with RLN
paralysis often registers a more significant loss of self which can be considerably more
distressing. Thus as with facial nerve paralysis, RLN paralysis can result in emotional
disturbances subsequent to the change in one of the sufferer’s defining features.

i. Anatomy & Etiology
The RLN follows a long and indirect course from where it branches off the vagus
nerve to its laryngeal entry (Figure 2). Its passage through the thorax and course through
the thyroid gland make it particularly vulnerable to damage during surgery involving the
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neck or thorax.

The RLN is one of the longest branches of the cranial nerves,

branching from the descending Vagus nerve at the level of the mediastinum, looping
around the aortic arch on the left and the subclavian artery on the right, then traveling
superiorly along the tracheo-esophageal groove. It enters the larynx on both sides behind
the articulation of the inferior cornu of the thyroid cartilage and the cricoids, where it
supplies sensory fibers to the internal surface of the larynx inferior to the vocal folds and
innervates all of the intrinsic muscles of the larynx, except the cricothyroid muscle. The
motor fibers stimulate abduction and adduction of the vocal cords for phonation,
breathing, and protection of the lungs during swallowing.
RLN injury is a known complication of surgery in the neck and thorax. It has
been reported that iatrogenic surgical injury to the RLN accounts for 46.3% of cases of
unilateral vocal fold paralysis; the majority of these procedures are thyroidectomies
(Rosenthal et al., 2007). Case series suggest that vocal fold palsy occurs in 1.8 – 4.7% of
thyroid surgeries (Erbil et al., 2007; Chan et al., 2006). Other procedures during which
the RLN is more prone to injury include anterior approaches to the cervical spine, open
heart surgery, carotid endarterectomy, and other surgeries to the neck and thoracic
regions. The nerve can also be compressed by tumor growth in the compact neck region:
thyroid, laryngeal and esophageal carcinomas; paragangliomas, and lung cancer are some
of the more common culprits (Myssiorek, 2004).

ii. Evaluation & Management
A variety of measures are used to assess vocal fold function, which includes voice
production, vocal fold mobility, and glottic closure. Voice quality is assessed with the
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vocal handicap index (Jacobson et al, 1997) and the grade of hoarseness, roughness,
breathiness, asthenia, and strain (GRBAS) scale (Hirano 1981). The vocal handicap
index is a questionnaire consisting of 3 subscales measuring functional, physical, and
emotional handicaps in verbal communication, with scores ranging from 0-120 increasing
in severity of dysfunction. The GRBAS scale assesses each of the five aforementioned
vocal dysfunctions on a scale of 0-3 (normal to severe). In addition to these subjective
measures, the vocal folds can be examined by laryngoscopy and videostroboscopy.
Visualization of the larynx can be done with a flexible or rigid endoscope in order to
observe the movement of the vocal folds. Videostroboscopy involves using a strobe light
to illuminate the vocal folds and parse out individual vibration cycles.

Stiffness,

irregularity of movement, and glottic closure can all be visually observed.
Intraoperative monitoring of nerve conductivity is standard procedure in operating
rooms during surgeries that put the RLN at risk; however, this has only been used as a
pre-emptive measure. Current surgical interventions focus on bringing the injured vocal
fold as medially as possible to improve contact with the other fold or directing another
intact but less important nerve to the laryngeal muscles. The medialization techniques
include injection laryngoplasty, which involves injecting a substance (collagen, tiny
beads) into the fold to increase bulk, and medialization laryngoplasty, which consists of
suturing the arytenoid cartilage in a medial position to the thyroid cartilage. These
approaches are clever but do not promote recovery of the injured RLN or movement of
the injured vocal fold. The anastomostic techniques all require the injury of a separate
intact nerve in order to reconnect it to either the injured RLN or the muscles of the
larynx.

Unfortunately these methods require the sacrifice of a healthy, though
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admittedly less vital, nerve and they yield variable success rates (Roh et al., 2009;
Aynehchi et al., 2010; Hartl et al., 2005; El-kashlan et al., 2001).

c. Sciatic Nerve Injury
Sciatica is a general term describing pain and/or numbness of the hip and lower
extremity due to pathologies affecting the sciatic nerve in its intraspinal or extraspinal
course. Up to 40% of adults experience sciatica at some point throughout their lives; its
most frequent cause is of intraspinal origin—a herniating lumbar disc pressing on the
neural roots (Ergun and Lakadamyali, 2010). Patients who undergo sciatic injury lose
motor function of the posterior compartment of the thigh as well as the entire leg in
addition to suffering from pain and numbness. The classic motor symptom usually first
reported in injuries involving the sciatic nerve is the foot drop, which is an inability to
dorsiflex the foot resultant from an impaired anterior tibialis muscle, as the motor axons
originating from the L4 and L5 nerve roots are the longest and the most susceptible to
injury. Patients with this symptom compensate by exaggerating the lifting of the thigh
during walking, producing a steppage gait which can produce balance defects. Impaired
locomotion, pain, and impaired balance leads to great distress for patients.

i. Anatomy & Etiology
The sciatic nerve is the largest and longest peripheral nerve in the human (and
rodent) body. Consisting of the axons from L4-S3, it measures approximately 2 cm in
diameter at the sciatic notch. It curves slightly to begin its descent into the thigh and
passes under the piriformis, where it can be trapped and compressed. From there, it
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descends within the sciatic sheath, passes deep to the biceps femoris, after which it
bifurcates at the apex of the popliteal fossa into the tibial and common peroneal nerves to
innervate both the posterior and anterior muscles of the leg and foot, respectively (Figure
3). Though it appears to be one nerve that splits in two, both the tibial and common
peroneal nerves have their own investing sheaths and axons from the two nerves do not
co-mingle.
Injury to the sciatic nerve can arise from a wide variety of causes including
traumatic injuries to the lower limb, neoplasms in the pelvis, thigh, and leg, lumbar
instability, spondylolisthesis, slipped discs, vertebral facet hypertrophy, piriformis
syndrome, herpes zoster, neurodegenerative diseases, and iatrogenic insults including hip
joint surgery and intramuscular injections, particularly those to the gluteus maximus.
Even a retroverted uterus can restrict and compress the nerve, causing damage (Ergun
and Lakadamyali, 2010; Kulcu and Naderi, 2008).

ii. Evaluation & Management
Because the joints of the lower limb have such wide ranges of motion, the
neuromuscular exam alone allows the clinician to localize nerve injury in the sciatic
distribution with a good degree of accuracy. Subsequent to examination of the reflexes,
strength, and range of motion, provocative tests have been devised to examine the sciatic
nerve.
quantify

Nerve conduction studies and electromyograms are typically performed to
nerve

damage.

Compound

muscle

action

potentials

and

needle

electromyograms are gathered from distal-most muscles first such as the extensor
digitorum brevis and the abductor hallucis (Derr et al., 2009; Masakado et al., 2008). As
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Figure 3: Course of the Right Sciatic Nerve. Arising from the lumbar plexus, the axons
from L4-S3 travel inferiorly in the posterior compartments of the thigh and leg to innervate
many target muscles. As it exits the pelvis, the sciatic nerve emerges from a small space
between the piriformis and the obturator internus and can be trapped here.. It is particularly
vulnerable to injury as it enters the popliteal fossa; while it is traversing this fossa in its most
superficial location along the lower limb, it is also dividing into the common peroneal and
tibial nerves to supply the muscles of the leg. From Gray’s Anatomy.
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with the facial nerve, a reduction in the compound muscle action potential suggests the
occurrence of axonal degeneration while an increase in latency indicates demyelination
(Kimura, 2006).
The sciatic and facial nerves share some medical and surgical interventions,
namely the administration of corticosteroids, decompression, anastomoses, and nerve
grafting. However, neurolysis, the removal of the outer layer of nerve sheath, has been
used in cases of iatrogenic injury to the sciatic nerve (Senes et al., 2009) as well as
electrical stimulation of the nerve to relieve pain. This stimulation is done with needle
electrodes; they can be placed percutaneously with or without ultrasound guidance or into
the area through an open surgical procedure (Chan et al., 2010). A portion of cases of
weakness are due to chronic, repeated injury such as by crossing the legs one over
another; these have good prognosis for spontaneous resolution. Injuries that require
surgical reanastomosis or nerve grafting typically have different management strategies
depending on the type of injury. In clean lacerating injuries in which the nerve ends are
visible and or obvious deficits result, immediate end-to-end repair may be warranted.
However, blunt transections due to lacerations tend to have better functional outcomes if
surgery is delayed, even up to a year depending on the severity of the injury (Kim and
Kline, 1996).
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4. ANIMAL MODELS

a. Facial Nerve Injury
Models of experimental facial nerve injury in animals described in the literature
include extratemporal transection and crush, intratemporal crush, and intracranial
transection of the facial nerve (Mattsson et al., 1999; Jones et al., 2001; Sharma et al.,
2009a). Thus far, an animal model of intracranial facial nerve crush injury has not been
well characterized even though a majority of intracranial facial nerve injuries result from
a stretching or compression of the nerve rather than a transection.

Effects from

extratemporal injuries were described by Nissl in 1892; since then, crush and transection
injuries have been studied extensively in rodents with great success in elucidating
molecular mechanisms underlying the injury response and subsequent repair process that
can occur in peripheral motoneurons.

Unlike humans, animals tend to recover

functionality rather quickly from crush (axonotmesis) injuries (Hetzler et al., 2008) but
complete functional recovery from transection (neurotmesis) injuries does not occur.
Since most of the cases of facial palsy are due to Bell’s palsy plus intracranial tumors and
complications regarding their removal, more clinically relevant models were needed.
Sharma and colleagues described a crush injury to the intratemporal portion of the nerve
while other groups developed ischemic models of facial nerve injury to model Bell’s
palsy (Sharma et al., 2009a; Takeda et al., 2008). Yet another group developed an
intracranial facial nerve transection model in rats; however, this model is not useful for
studying the effects of therapy on functional recovery as it results in neurotmesis and the
ends are left separated (Mattsson et al., 1999; Mattsson et al., 2006). One study involving
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an intracranial crush was published by this group but they only observed their animals
for three weeks after injury (Mattsson et al., 2001). To date, no reliable injury model has
been demonstrated for the purpose of studying functional recovery after intracranial
facial nerve injury.

b. Recurrent Laryngeal Nerve Injury
Animal models of experimental RLN injury include crush, transection, and
transection with end-to-end repair. The phenomenon of synkinesis, due to aberrantly
regrowing axons reinnervating the wrong muscles, has been documented in a transectionrepair model (Flint et al., 1991). However, until recently, most of the literature in this
model has focused on the transection or transection-repair models since rodents display
spontaneous behavioral recovery following both types of injuries (Bamba et al., 2000;
Nakagawa et al., 2004). The timeline of behavioral recovery in rats that have undergone
a RLN crush injury has been established, but it is a relatively new model system as
compared to the facial nerve axotomy (Tessema et al., 2009; Shiotani et al., 2007).

c. Sciatic Nerve
Experimental models of sciatic nerve injury in animals are varied, ranging from
clip-compression to transection and repair to chronic denervation. Because of its large
size as well as its ease of dissection and manipulation, it is ideal to work with in rodent
models of nerve injury. Additionally, since a well-functioning sciatic nerve is vital to
appropriate gait in rodents, injuries can be easily studied at both macro and micro levels
and related to human function. Gait analysis post-injury has advanced from dipping hind
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paws in paint in order to record the footprints to using video capture of rodents
traversing illuminated walkways and dynamic analysis using treadmill walking
(DeMedinacelli et al., 1982; Deumens et al., 2007; Beare et al., 2009). The sciatic nerve
has also been used to examine the soma response to axonal disconnection as well as the
molecular regenerative response post-injury, as there are some differences between spinal
and cranial motoneurons (Powell et al., 1979; Schlaepfer and Hasler, 1979). Nerve
grafting techniques have been practiced on rodent sciatic nerves, as well as promising
graft substances been tested in rodents models of sciatic injury (Richardson et al., 1982;
Waitayawinya et al., 2007). The sciatic nerve crush axotomy model has been well
studied in rodents and the timeline for functional recovery is documented (Forman and
Berenberg, 1978; Alberghina et al., 1983; Walker et al., 1994; Brown et al., 1999; Ferri
and Bisby, 1999; Oliveira et al., 2001; Lago and Navarro, 2006). Sciatic transection,
repair, and grafting techniques have been similarly studied; however, due the lack of a
patent epineurium in these models, the functional recovery timeline has significantly
greater variability (Hare et al., 1992; Ijkema-Paassen et al., 2002; Hamilton et al., 2011).

C. NEUROTHERAPEUTIC ROLE OF GONADAL STEROIDS
A variety of hormones, including gonadal steroids, glucocorticoids, and thyroid
hormones, have been examined as neurotherapeutic agents for the injured or diseased
nervous system.

The many studies on gonadal steroids have distinguished them as

potential agents for therapy. Estrogen affects not only learning, memory, behavior and
cognition, but has also been shown to have neuroprotective and neuroregenerative effects
(Green et al., 1997; McEwen and Alves, 1999; Matsumoto and Arai, 1981). Progesterone
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has been shown to rescue motoneurons from degeneration and promote recovery from
spinal cord injury (Thomas et al., 1999; Gonzalez et al., 2002). Androgens have been
demonstrated to have a neurotherapeutic impact on various disease conditions and to
enhance peripheral nerve regeneration, as described below.

1. ANDROGENS
Androgens have a wide variety of functions due to their ability to target numerous
body tissues, including reproduction, development of primary and secondary sexual
characteristics, increasing muscle mass, and affecting neuronal functioning.

During

development of the nervous system, the presence or absence of androgens determines
gender-specific morphological and behavioral patterns of the adult (Kaiser and Morley,
1994; Beyer and Hutchison, 1997). Within the brain, androgens not only exert long-term
organizational (permanent) effects during the developmental period, but they also have
transient activation (reversible) effects during regenerative events (Arnold and Gorski,
1984).
Gonadal steroids are synthesized from cholesterol primarily in the adrenal cortex
and the gonads (Champe and Harvey, 1994). The majority of testosterone production
takes place in the Leydig cells of the testes. After it is secreted, testosterone is delivered
via protein-bound transport to target organs. Approximately 60-70% of testosterone is
tightly bound to sex hormone binding globulins (SHBG), 30-40% is bound loosely to
albumins, and 0.5-2% is free (Iqbal et al., 1983). In addition to differences in production
levels between the sexes, gender differences in SHBG levels influence the circulating
levels of testosterone in males and females (Bialek et al., 2004). Also, the increase in
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SHBG levels over time reduces the levels of free testosterone (Leifke et al., 2000).
Free testosterone can cross the blood brain barrier and have effects on the CNS and the
PNS (Champe and Harvey, 1994). Its lipid solubility allows the hormone to easily cross
the cell membrane and bind to its intracellular receptor, the androgen receptor (AR).
Testosterone can act either directly through an androgen pathway or indirectly through its
aromatization to estrogen.

2. MECHANISM OF ACTION
Steroid hormones act on the nervous system using two different mechanisms,
genomic and non-genomic. The genomic mechanism is slow-acting and involves binding
of the hormone to its nuclear receptor. Subsequent binding of the hormone-receptor
complex to DNA sites called hormone response elements acts to alter gene expression
(Beato, 1989). The non-genomic mechanism is fast-driven and involves interaction of
the hormone with membrane or neurotransmitter receptors (McEwen, 1991; Falkenstein
et al., 2000). Steroid utilization of one or both of these mechanisms leads to changes in
cells of the nervous system and effects on neurotropism and regeneration.
The presence of nuclear ARs in various regions of the brain and spinal cord
allows testosterone to exert genomic effects. The distribution of ARs has been identified
autorardiographicaly,

biochemically

and

with

in

situ

hybridization

and

immunocytochemical methods (Morrell and Pfaf, 1978; McEwen et al., 1982; Simerly et
al., 1990). ARs are predominantly found in the medial hypothalamic area, ventromedial
and dorsomedial nucleus, preoptic area, arcuate nucleus, amygdala, regions of the
hippocampus, and lower motoneurons of the brainstem and spinal cord (Ozawa, 2005;
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Sar and Stumpf, 1977; Yu and McGinnis, 2001). There are sex-related differences in
AR distribution, with males having higher concentration of the AR protein than females
(Lu et al., 1998). Exposure to gonadal steroids induces rapid ultrastructural changes,
including alterations in the nucleolus and rough endoplasmic reticulum, increase in cell
size, and increase in nuclear size and change in nuclear shape from normal ellipsoid to
spherical (Cohen and Pfaff, 1981; Jones et al., 1990). The interval between rRNA
transcription and processing is also shortened in the presence of gonadal steroids
(Kinderman and Jones, 1993).
In the mouse facial motor nucleus (FMN), AR mRNA is localized to the
cytoplasm but becomes concentrated to the nucleus upon treatment with testosterone
(Tetzlaff et al., 2007a). Therefore, androgens may have genomic as well as non-genomic
effects within the FMN. Unbound steroid receptors are known to complex with heat
shock proteins (hsp; Pratt and Toft, 1997). AR has been shown to associate with hsp70 in
prostatic cell lines (Veldscholte et al., 1992). Thus, the administration of androgens may
mediate the cell response following neuronal injury by binding to ARs and releasing
hsp70.

Previous studies from our laboratory have shown that hsp70 mRNA levels

increase by 364% following facial nerve transection in hamsters (Jones et al., 2000). The
administration of testosterone, however, prevents this increase, suggesting that it
substitutes the need to synthesize hsp70 by making available pre-existing hsp70. This
mechanism would allow injured neurons to mount a regenerative response more
immediately, without the need to mount a stress response first. Additional studies from
our laboratory have demonstrated that application of testosterone increases the rate of
axonal regeneration, but does not decrease the time to neuronal sprout formation,
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suggesting that genomic mechanism predominates during the injury response (Sharma
et al., 2009b). Furthermore, testosterone administration induces significant upregulation
in the regeneration-associated genes βII-tubulin, brain-derived neurotrophic factor
(BDNF), and neuritin and does so in a delayed fashion, between 2 and 7 days postaxotomy (Sharma et al., 2010b).

3. ROLE IN PERIPHERAL NERVE REGENERATION
Androgens’ therapeutic effects following peripheral nerve injury have been
examined in several model systems. Our lab has investigated the role of gonadal steroids
in the neuronal reparative process using a hamster facial nerve axotomy model, in which
the facial nerve is crushed or transected at its exit from the stylomastoid foramen (SMF).
Initial studies were aimed at determining the effects of a testosterone ester, testosterone
propionate (TP), on functional recovery following a facial nerve crush in adult male
Syrian hamsters (Kujawa et al., 1989). Varying doses and administration methods of TP
were tested: 1) subcutaneous injection of TP in sesame oil vehicle every other day, 2)
subcutaneous injection of TP in sesame oil vehicle every day, and 3) subcutaneous
Silastic implants containing TP. Results demonstrated accelerated functional recovery in
all groups treated with TP, along with a dose-response relationship. Higher and more
frequent doses of TP had better effects on functional recovery, with the continuous dose
achieved by Silastic implants having the most enhanced effects.

Additionally,

gonadectomized male hamsters did not display different recovery from gonadally intact
animals, indicating that normal endogenous levels of testosterone were not effective.
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Next, the effects of TP on rate of facial nerve regeneration following a facial
nerve crush at the nerve’s exit from SMF were examined; it was found that testosterone
administration increased the regeneration rate by 26-30% (Kujawa et al., 1991).
Additionally, our lab has found that treatment with testosterone metabolites,
dihydrotestosterone (DHT) and estrogen, increase regeneration rates as well (Tanzer and
Jones, 1997). The effects of testosterone on molecular events have also been investigated
in the facial nerve axotomy model. Results demonstrate that TP selectively upregulates
regeneration-associated genes such as β II-tubulin, growth cone-associated protein-43
kilodaltons (GAP-43), BDNF, and neuritin and decreases expression of glial fibrillaryacidic protein (GFAP) in the FMN (Jones and Oblinger, 1994; Jones et al., 1997a; Jones
et al., 1997c; Sharma et al., 2010b). TP increases the rate of axonal regeneration, but
does not decrease the time to neuronal sprout formation (Kujawa et al., 1991; Sharma et
al., 2009b).

TP administration also has a pronounced effect on synaptic stripping

following facial nerve transection in hamsters (Jones et al., 1997b).

TP preserves

approximately half of the axosomatic synapses that are otherwise removed in untreated
animals, implying that TP treatment may reduce the initial shock to injured neurons.
Other peripheral nerve injury models also reinforce the neurotherapeutic role of
gonadal steroids in nerve regeneration. Yu and Srinivasan (1981) have shown that TP
administration enhances hypoglossal nerve regeneration in rats.

TP also increases

regeneration in rat sciatic motoneurons and accelerates functional recovery following
hind limb paralysis (Kujawa et al., 1993; Brown et al., 1999). Vita et al. (1983) have also
reported the accelerative effects of androgens on sciatic nerve regeneration in male
rabbits. Apart from enhancing axonal regeneration, administration of DHT and estrogen
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reduces loss of facial motoneurons following facial nerve transection in neonatal
hamsters (Huppenbauer et al., 2005). Perez and Kelley (1996) also found that androgen
treatment enhanced laryngeal motoneuron survival in Xenopus laevis.

Therefore,

treatment with androgens is a viable therapeutic strategy for peripheral nerve injuries.

D. NEUROTHERAPEUTIC ROLE OF ELECTRICAL SITMULATION
Electrical activity occurs naturally within the nervous system and plays an
important role from development to adulthood. Application of electrical fields affects
morphological and functional properties of neurons such as nerve branching, rate and
orientation of neurite growth, rapid sprouting, and guidance during axon regeneration
(McCaig, 1990; Borgens et al., 1981; Patel and Poo, 1982; Manivannan and Terakawa,
1994; Borgens, 1999; Wan et al., 2010). Electrical stimulation (ES) has been explored as
a potential treatment for a variety neurobiological diseases, including movement
disorders, seizures, psychiatric disorders, chronic pain syndromes, and peripheral nerve
and spinal cord injuries (Wan and Lin, 2009).

1. HISTORY OF ELECTRICAL STIMULATION
Early in vitro experiments investigated the effects of ES on morphological
properties of neurons. Jaffe and Poo (1979) demonstrated that neurites react rapidly to an
applied direct current (DC) field by orienting themselves parallel to the gradient. McCaig
(1990) found that applying electric fields to Xenopus laevis further affected neurite
morphology by increasing the number of filopidia at the growth cone and the number of
cytoplasmic spines along a neurite shaft and by enhancing nerve branching. Application
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of steady electric gradients across injured spinal cords of guinea pigs has been found to
promote both anatomical and functional recovery (Borgens et al., 1987).
ES also improves survival of neuronal populations following axotomy in the
CNS. ES of the transected optic nerve for 2 h promoted survival of retinal ganglion cells
following transection of the optic nerve in rats (Morimoto et al., 2002). Okazaki et al.,
(2008) have further examined the different ES parameters of optic nerve stimulation.
While 10 min of ES was found to be ineffective, 30 min of ES was as effective as 1 h and
2 h of ES in enhancing neuronal survival. Frequency of ES also affected neuroprotection,
as a frequency of 20 Hz was found to be optimal, with lower (10 Hz) and higher (50 Hz)
frequencies having no beneficial effect. Others have also confirmed the success of the
20Hz stimulation frequency (Ahlborn et al., 2007; Wan et al., 2010; Alrashdan et al.,
2010). Our laboratory has found that a one-time, 30 min application of 20 Hz ES
promotes recovery from both extratemporal and intratemporal facial nerve crush (Hetzler
et al., 2008).

In short, a variety of experiments over the past three decades have

established that ES provides directional cues, influences orientation and regeneration in
vitro and in vivo, promotes survival of CNS neurons, and accelerates functional recovery
following spinal cord injury.

2. EMERGING ROLE IN PERIPHERAL NERVE REGENERATION
Though ES has been shown to affect neuronal properties and neuronal survival
and regeneration post-injury positively, administration techniques vary widely ranging
from daily, prolonged individual periods, to one-time brief stimulation (Nix and Hopf,
1983; Pockett and Gavin, 1985). Although such studies were essential in establishing
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that ES accelerated functional recovery following peripheral nerve injury, they did not
determine the anatomical reasons underlying the results. To achieve this, Al-Majed et al.
(2000a) used the rat femoral nerve model of transection and surgical repair to examine
the ability of ES to accelerate axonal regeneration and promote reinnervation specificity.
The 20 Hz frequency was used because it is similar to the normal slow firing patterns of
motoneurons. They found that 1 h to 2 weeks of electrical stimulation increased the
number of regenerated axons farther from the site of injury as well as those that went into
the appropriate branch.

Other experiments using proximal labeling and histological

techniques revealed that 1 h ES of the femoral and sciatic nerves increased the number of
axons that regenerated across the suture gaps (Brushart et al., 2002; Vivo et al., 2008).
ES has also been found to improve both motor and sensory recovery from sciatic crush
injury (Alrashdan et al., 2010).
The above rat studies have been translated to humans in whom the median nerve
had been damaged from carpal tunnel syndrome (Gordon et al., 2007). The median nerve
was stimulated for 1 h during carpal tunnel release surgery in a randomized clinical trial,
increasing the motor unit number estimates and accelerating functional recovery in
patients. Given these findings, ES can be used as a strategy to improve the outcome of
peripheral nerve injury.

3. MECHANISM OF ACTION
The mechanism of action of ES is not completely understood. An experiment
using the rat femoral nerve model of transection and surgical repair determined that the
regeneration-associated effects of ES were mediated by the cell body (Al-Majed et al.,

2000a).
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Transected and repaired femoral nerves in rats were stimulated with or

without the application of tetrodotoxin (TTX; blocker of voltage-gated sodium channels)
at a dose that completely blocks electrical transmission toward the proximal cell body.
TTX completely abolished the previously seen effects of ES, suggesting that it acts to
enhance the growth program initiated by the cell body after injury.
Subsequent studies demonstrated that ES first enhanced the upregulation of
BDNF and its trkB receptor in axotomized rat femoral motoneurons (Al-Majed et al.,
2000b) and then upregulated GAP-43 and cytoskeletal proteins (actin and α1-tubulin) and
downregulated neurofilaments (Al-Majed et al., 2004). Since neurofilaments interfere
with axonal transport of actin and tubulin, this decrease in neurofilament to tubulin ratio
was also associated with enhanced regeneration (Bisby and Tetzlaff, 1992). English et al.
(2007) have further demonstrated that the lack of neurotrophin-4/5 (NT-4/5) in transgenic
mice abolishes the enhanced regeneration induced by ES. Therefore, an increase in
neurotrophic factor production appears to be an essential downstream effect of ES. Our
laboratory has confirmed that ES treatment results in upregulated BDNF as well as other
the regeneration-associated genes α1-tubulin, GAP-43, neuritin, and pituitary adenylate
cyclase-activating peptide (PACAP) after facial nerve crush (Sharma et al. 2010b).
These genes have increased expression in the first few days after injury, which correlates
well with the finding that the delay to sprout formation is decreased after application of
ES (Sharma et al., 2009b).
ES is thought to mediate changes in the expression of regeneration-associated
genes by increasing intracellular levels of cyclic adenosine monophosphate (cAMP), an
intracellular second messenger (Gordon, 2009). This early increase in cAMP associated
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with ES is most likely preceded by increased calcium entry into the cell body, the
importance of which was suggested when Kerns and colleagues found that the application
of verapamil, a calcium-channel blocker, reduced the regenerative effects of ES (Kerns et
al., 1991). However, administration of a specific phosphoesterase IV inhibitor of the
neuronal enzyme that hydrolyses cAMP, rolipram, mimics the enhanced regenerative
effects of ES (Gordon, 2009). ES may work through additional mechanisms other than
stimulating neural cells to synthesize regeneration-associated gene products. Wan and
Lin (2009) recently postulated that ES of injured nerves may accelerate the transport of
mRNAs to axons, which would likely improve axonal elongation; subsequently Wan and
colleagues (2010) found that ES affects Schwann cell polarization by upregulating
expression of P0 and Par-3, two genes involved in determining cell polarity, along with
BDNF.

E. COMBINATORIAL TREATMENT STRATEGY
Based on the numerous studies reporting that gonadal steroids and ES positively
affect nerve regeneration individually and the studies from our laboratory demonstrating
that the two therapies approach different aspects of the regenerative process, it would be
logical to examine the effects of combining both treatments. Sharma and colleagues
found that the combination of TP and ES accelerated functional recovery in the
extratemporal and intratemporal facial nerve injury models more than either alone. The
effects of the two treatments were additive in the extratemporal injury, but were even
more striking in the intratemporal injury: untreated animals only partially recovered
within the time frame of the study, whereas 100% of the combinatorially treated animals
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completely recovered by the end of 8 weeks (Hetzler et al., 2008; Sharma et al.,
2010a). The models of facial nerve injury currently in use do not simulate the most
proximal injuries well, so there is a need to develop an animal intracranial model of facial
nerve injury. It also remains to be seen whether this combinatorial treatment can improve
other injured peripheral nerves other than the facial, such as the recurrent laryngeal and
sciatic nerves. Therefore, the overall goal of this dissertation is to investigate the
therapeutic effects of ES and testosterone in combination, in a variety of
translational peripheral nerve injury models, the proposed intracranial facial nerve
crush, the recurrent laryngeal nerve crush, the sciatic nerve crush, and the sciatic
nerve transection-repair.

CHAPTER III
MATERIALS AND METHODS

A. ANIMALS
All animals used in the present study were adult, male Sprague-Dawley rats (2
months old or ~250 g), purchased from Harlan (Indianapolis, IN). Animals were allowed
to acclimate to their environment for at least 3 days upon arrival, prior to any
manipulation. Rats were housed under a 12 h light/dark cycle in microisolator cages and
received a standard rodent diet and water ad libitum except during CatWalk apparatus
behavioral training. All surgical procedures were completed in accordance with the
National Institutes of Health guidelines on the care and use of laboratory animals for
research purposes and approved by the institutional animal care and use committee.
Sterile, aseptic techniques were used throughout the study.

Any animals

displaying ≥15% weight loss were removed from the experiment. Wound clips and
sutures were removed 10-14 days post-operative (dpo). Ketamine/xylazine overdose and
intracardiac perfusion with room temperature saline followed by ice-cold 4%
paraformaldehyde in phosphate-buffered saline (PBS) was used to sacrifice all animals at
the appropriate post-operative survival time.
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B. SURGICAL PROCEDURES

1. GONADECTOMY
Gonadectomies were performed 3-5 days prior to facial, recurrent laryngeal, or
sciatic nerve injury. Animals were anesthetized with 3.5% isofluorane and the surgical
area was prepped with 70% ethanol and povidone-iodine. A 5 mm incision between the
penile and the anal openings was made and both testicles were pulled through one at a
time. The testicular and epididymal arteries were ligated bilaterally with 4-0 silk suture,
and testicles were severed distal to the sutures. The wound site was closed with 9 mm
wound clips and animals were allowed to recover under observation.

2. INTRACRANIAL FACIAL NERVE CRUSH AXOTOMY
Animals were anesthetized by intraperitoneal injections of Ketamine (100 mg/ml;
0.1 ml/100g body weight) and Xylazine (20 mg/ml; 0.025 ml/100g body weight). All
crush-axotomies were performed on the right facial nerve, with the left facial nerve
remaining intact and serving as an internal control in each animal. The right postauricular area was shaved and prepped with 70% ethanol and providone-iodine solution
and a curvilinear incision was made ~5 mm behind the ear with a #15 scalpel blade. The
skin was elevated in the subdermal plane towards the ear canal. The extratemporal
portion of the facial nerve was identified as it exited the stylomastoid foramen. The
nuchal crest was identified between the superficial temporal muscle anteriorly and the
splenius capitis muscle posteriorly. These two muscles were then incised and dissected
off the skull. The splenius capitis muscle was resected back to the skull base and a small
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portion of the temporalis muscle was excised to provide improved exposure to the
occipital squama and the mastoid process of the petrous temporal bone (Figure 4). The
resected muscle was stored in room temperature 0.9% saline during the rest of the
surgery to be used as a muscle plug at closing to prevent cerebrospinal fluid leak from the
craniotomy defect.
Using a high-speed drill with a 2-mm diamond burr under microscopic
visualization, the nuchal crest was thinned in a saucerized manner to reveal the transverse
sinus. A #3 French suction-irrigator was used to bathe the operative field in room
temperature 0.9% saline to prevent thermal injury to the temporal bone and the facial
nerve from the drilling procedure. Next a craniotomy was made into the occipital
squama until dura was seen, with the transverse sinus as the anterior limit (Figure 5).
Using both epinephrine-soaked pellets and a small retractor, the parafloccular lobe of the
cerebellum was retracted superiomedially. The drill was used to widen the craniotomy
superiorly until the inferior cerebellar vein and mastoid cavity was identified. Posteriorly
the craniotomy was widened to the end of the occipital squama bone. This created
approximately a 3 x 3-mm craniotomy through which the petrous portion of the temporal
bone was visualized (Figure 6).
With a 1-mm diamond burr, deeper dissection was performed to identify the
petrous portion of the temporal bone. Staying posteriorly, the vestibulocochlear nerve
was identified (Figure 7) and sacrificed. The vestibulocochlear canal was followed
laterally until the cochlea was identified and entered. This area was widened anteriorly
until the posterior wall of the facial nerve was skeletonized. A thin portion of bone was
left over the facial nerve to protect it until final unroofing. Drilling was then performed
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anterior to the facial nerve (Figure 8) to allow room for forceps. This allowed for a
circumferential view of the labyrinthine segment of the facial nerve.
Once the facial nerve was sufficiently skeletonized, a Rosen needle was used to
remove the remaining bone from the surface of the nerve (Figure 9). Because the nerve
is anchored at the first genu, it is extremely susceptible to damage from microscopic
movements during the crush injury. To solve this dilemma we ensured that the nerve was
mobile within the canal so that microscopic movements could be absorbed by movement
of the brainstem.

Curved jewler’s forceps (#5 x 45) were then inserted into the

craniotomy site and the intracranial portion of the facial nerve between the brainstem and
meatal foramen was crushed firmly once for one minute. Due to limited access to the
nerve, the nerve could only be crushed in one orientation (from the top). Care was taken
to avoid suction or manipulation of the nerve immediately after the crush to avoid
transection. A 3x3 mm small muscle plug was inserted into the craniotomy site to
prevent cerebrospinal fluid leak. A 10x15 mm large muscle plug was placed over the
craniotomy site to serve as a second layer of closure. The muscle and skin layers were
closed separately.
Successful crush was verified by complete loss of the eyeblink reflex and loss of
vibrissae orientation and movement in animals upon recovery from anesthesia. The
injury paradigm severed the axons but left the neural sheath intact to provide a route for
regenerating axons. The wound site was sutured with 4-0 prolene and coated with triple
antibiotic ointment (Henry Schein).
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Figure 4. Superficial Dissection of Muscle and Bone for the Intracranial Facial Nerve Crush – Layer 1.
The temporalis and splenius muscles have been removed to expose the following structures: FN-ET: Facial
Nerve extratemporal, NC: Nuchal Crest, STM: Superficial Temporal Muscle (Resected), SCMr: splenius capitis
muscle (Resected), OC: Occipital Squama, MP: Mastoid Process of the petrous temporal bone, Dotted line:
Approximate area of initial craniotomy. L, lateral; M, medial; A, anterior and toward the snout; P, posterior.
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Figure 5. Initial Craniotomy for Intracranial Facial Nerve Crush – Layer 2. The bone has been sufficiently
thinned to expose brain tissue, yet the surrounding structures are intact: FN-ET: Facial Nerve extratemporal,
STMr: Superficial Temporal Muscle (Resected), SCMr: splenius capitis muscle (Resected), MP: Mastoid Process
of the petrous temporal bone, TS: transverse sinus, Dotted line: Approximate boundary between bone and brain
during initial craniotomy. L, lateral; M, medial; A, anterior and toward the snout; P, posterior toward the tail.
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Figure 6. Craniotomy for Intracranial Facial Nerve Crush – Layer 3. Note animal rotated 90 degrees. FNET: Facial Nerve extra-temporal, TS: Transverse Sinus, STM: Superficial Temporal Muscle (Resected), SCMr:
splenius capitis muscle (Resected), Crani: Craniotomy with Parafloccular lobe of cerebellum retracted, MP:
Mastoid Process. Dotted line: outline of exposed parafloccular lobe of cerebellum. L, lateral; M, medial; A,
anterior and toward the snout; P, posterior toward the tail.
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Figure 7. Magnified View of Widened Craniotomy for Intracranial Facial Nerve Crush – Layer 4. Note
animal rotated 90 degrees. The craniotomy measures 3 mm at its widest. FN-ET: Facial Nerve extra-temporal,
TS: Transverse Sinus, STMr: Superficial Temporal Muscle (Resected), SCMr: splenius capitis muscle
(Resected), 8th Nerve: Cochlear Nerve prior to sacrifice. L, lateral; M, medial; A, anterior and toward the snout;
P, posterior toward the tail.
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Figure 8. Craniotomy for Intracranial Facial Nerve Crush – Layer 5. Note animal rotated 90 degrees.
Drilling both anteriorly and posteriorly to the facial nerve is necessary for a complete crush . FN-ET: Facial Nerve
Extratemporal, FN-IC: Facial Nerve Intracranial, TS: Transverse Sinus, STMr: Superficial Temporal Muscle
(Resected), SCMr: splenius capitis muscle (Resected), 8th Nerve-S: Cochlear Nerve Sacrificed. L, lateral; M,
medial; A, anterior and toward the snout; P, posterior toward the tail.
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Figure 9. Intracranial Facial Nerve Crush. Note animal rotated 90 degrees. Rosen Needle pointing to
skeletonized nerve and subsequent crush site. FN-ET: Facial Nerve Extratemporal, FN-IC: Facial Nerve
Intracranial, TS: Transverse Sinus, STMr: Superficial Temporal Muscle (Resected), SCMr: splenius capitis muscle
(Resected). L, lateral; M, medial; A, anterior and toward the snout; P, posterior toward the tail.
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3. RECURRENT LARYNGEAL NERVE CRUSH AXOTOMY
Animals were anesthetized with isoflurane as described above and breathing rate
was monitored throughout the surgery. The ventral neck area was shaved between the
mandible and clavicle and then the animal was secured supine in a stereotaxic skull frame
in order to stabilize the head and expose the neck. Direct laryngoscopy (described later
in section 3-E-3) was performed before nerve exposure to document normal vocal fold
motion prior to nerve injury. The neck area was prepped and a 2 cm midline incision was
made in the skin between the hyoid and clavicle. Under a dissecting microscope, the
midline strap muscles (sternothyroid and sternohyoid) were separated and retracted to
expose the trachea and both left and right RLNs were visualized along the sides of the
trachea. The left RLN was gently freed from the pretracheal fascia, its connective tissue
attachment to the trachea, by #5 dumont forceps between the levels of the 5th – 9th
tracheal rings. The nerve was crushed for 30 sec, twice with the same forceps used to
dissect out the nerve at the 7th tracheal ring. After verification and documentation of
successful crush with direct laryngoscopy, muscle layers were reapproximated and the
overlying skin closed with wound clips as well as coated with triple antibiotic ointment.

4. SCIATIC NERVE CRUSH AXOTOMY
Animals were anesthetized with isoflurane and monitored as described above.
After the right thigh was shaved and prepped, the right hind limb was secured to the
operating surface with surgical tape to prevent movement. A 2.5 cm incision was made
on the postero-lateral surface of the thigh along the grain of the biceps femoris beginning
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5 mm distal to the greater trochanter of the femur. The cranial and caudal heads of the
biceps femoris (corresponding to the short and long heads in humans) were separated and
retracted to reveal the femur and the sciatic nerve. The sciatic nerve was then freed from
the fascia securing it to the femur and adductor muscles and subsequently crushed twice
for 30 sec each with jeweler’s forceps at the midpoint of the femur. Muscle layers were
reapproximated and the overlying skin closed with wound clips.

5. SCIATIC NERVE AUTOGRAFT AXOTOMY
The sciatic nerve autograft surgery was conducted in the same manner as the
sciatic crush injury up to the crush. However, instead of performing a crush injury, the
nerve was transected through its circumference (including through the epineurium) at two
places 7 mm apart and the epineurium reattached with sutures. In order to do this, before
the transections took place, 2-3 knot preparations were placed around the circumference
of the nerve so that immediately after the nerve was cut the nerve could be
reapproximated. Retraction of the biceps femoris muscle used to expose the sciatic nerve
also stretches it, so the nerve will shorten after it is cut. In order to minimize this
shortening and thus the subsequent increase in tension needed to reapproximate the cut
ends, the knot preparations were placed before each cut. A knot preparation consisted of
a 10-0 nylon suture threaded lengthwise through the nerve twice (see Figure 10) with a
slack loop of suture in between stitches, providing a base for the knot. These threads
were then pulled taught together after the cut, held together with hemostatic clips, and
tied individually. After both cuts were made and repaired with suture, the overlying
muscle layers were reapproximated and the overlying skin closed with wound clips.

1

2

3

4
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Figure 10. Knot Preparation. In order to facilitate suturing cut ends of the sciatic nerve back together for the autograft procedure,
suture was threaded through the epineurium before the nerve was transected. 1 shows the needle piercing the epineurial layer. 2 shows
the thread pulled through the path left by the need. 3 shows the full loop in place. 4 is after the transection occurs; the two nerve
sections are still connected by the thread. The ends can be pulled taught in order to re-secure the nerve sections to one another.
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C. ELECTRICAL STIMULATION

1. DESIGN OF ELECTRODE APPARATUS
A custom electrode apparatus was constructed in our laboratory for use in rats.
Two Teflon-coated wires (Cooner Wire, Chatsworth, CA) were bared of insulation for 23 mm and soldered to two “male” connector pins (Wire Pro) in a connector strip (Allied
Electronics). The connector pins soldered to the wires were covered with insulation
tubing (Allied Electronics) and epoxy and allowed to dry overnight. One of the wires and
its respective connector pin was marked with red insulation tape to designate it as the
positive end of the electrode while the other wire and its connector pin were left
unmarked to designate that as the negative end. All electrode apparatuses were tested
with a voltmeter to ensure that they were functional prior to use in animals.

2. ELECTRICAL STIMULATION IN ANIMALS
In all nerve injury paradigms, electrode leads were sutured in place at the time of
axotomy and removed immediately after the singular stimulation session was complete.
Stimulation was done while the incision for the axotomy injury was open to simulate a
human operating room situation. For the intracranial facial nerve crush axotomy, the
positive wire was sutured proximal to the crush site adjacent to the facial nerve, while the
negative wire was sutured ~3-5 mm away onto surrounding connective tissue. For the
RLN crush axotomy, the positive wire was bent around the left RLN after it was
dissected away from the larynx proximal to the crush site at or below the level of the 9th
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tracheal ring and did not need suture to be held in place; the negative wire was sutured
to the retracted strap muscles. For the sciatic nerve crush and resection-repair injuries, as
with the RLN stimulation, the positive wire was bent around the sciatic nerve proximal to
the crush injury or the more proximal resection-repair site and the negative wire sutured
to the retracted biceps femoris. The connector pins of the electrode were connected to the
leads of an isolated pulse stimulator (W-P Instruments, Inc.), and current was directed
from the negative to the positive lead.

Voltage was increased slowly and set at a

threshold at which animals displayed a right ear flutter, a left vocal fold flutter, or a right
hind limb twitch depending on the model. This voltage was measured to be between 200
and 300 mV for all animals and injury models. The supramaximal, monophasic pulses
were delivered at a frequency of 20 Hz after the injury. Unstimulated animals were
connected to the stimulator, but the voltage was kept at 0 V.

D. STEROID ADMINISTRATION

1. TESTOSTERONE PROPIONATE
TP was administered using subcutaneous capsule implants. Capsules were made
of Silastic tubing (0.062 in. ID x 0.095 in. OD) and were 18 mm in total length. Of this
length, 10 mm contained 100% crystalline TP (Sigma) while 4 mm wooden plugs sealed
both ends of the capsule. Prior to use in animals, capsules were equilibrated overnight in
physiological saline. In each animal receiving TP treatment, 2 capsules were implanted
at the time of axotomy. A subcutaneous pocket for the capsules was created by making
an incision on the mid-dorsal surface of animals or using the same incision site used for
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electrode implantation. Capsules were left in animals until the time of euthanasia. This
dose of TP has previously been shown to establish supraphysiological levels of systemic
testosterone (Hetzler et al., 2008; Tanzer and Jones, 2004; Kujawa et al., 1989).

E. BEHAVIORAL TESTING

1. FACIAL NERVE FUNCTIONAL RECOVERY TESTING
In rodents, a complete crush or transection of the facial nerve results in ipsilateral
loss of the eyeblink reflex, backwards vibrissae orientation, loss of vibrissae movement,
and drooping of the mouth, and return of facial nerve function can be easily observed.
Animals were allowed to roam freely in an empty cage, placed on a black background, to
observe return of vibrissae orientation and movement. To elicit the eyeblink reflex, a
puff of air was blown into the animal’s eye and the extent of eyelid closure was observed.
Since symmetry of the mouth in rats was not obvious from observation alone and could
not be easily scored, improvement in mouth droop was not used as an analysis parameter
for facial nerve function.
For the facial functional recovery study described herein, function on the crushed,
right side was always compared to the intact function on the left side using a 3-point
recovery scale. A score of ‘1’ was used to indicate complete lack of function, ‘2’ to
indicate the onset of any return in function, and ‘3’ to indicate complete, symmetrical
function as compared to the left side. Recovery time for each functional parameter
(eyeblink reflex, vibrissae orientation, and vibrissae movement) was defined as the
number of dpo until the animals received a score of ‘3’. For eyeblink function, the
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number of dpo until the onset of the reflex (score of ‘2’) was also analyzed.
Behavioral observations were conducted daily in all animals until a score of ‘3’ was
attained for all functional parameters. Complete functional recovery was defined as the
number of dpo when all of the parameters had returned to normal.

2. FACIAL NERVE CONDUCTION TESTING
Motor nerve conduction studies were performed weekly, beginning on the day of
axotomy and continuing until the day of sacrifice. Animals were anesthetized with
intraperitoneal injections of Ketamine-Xylazine, as described in the previous section. A
total of 5 electrodes (Grass Technologies, Astro-Med, Inc.) were used for testing. Two
stimulating electrodes were placed below the infraorbital ridge to stimulate the facial
nerve, while two recording electrodes were placed on the vibrissae pad to record the
response. As the vibrissae pad in rats contains organized rows of indentations, the
placement of electrodes could be easily replicated for each recording. A ground electrode
was placed inferior to the external ear.

Electrodes were connected to an

electomyographic machine (Advanced Medical) that stimulated and displayed the
response. The size of the response (amplitude) in mV and the time in ms (latency) for the
electrical impulse to travel from the stimulation to the recording site were the two
parameters used to analyze facial nerve conduction.
The optimal parameters used for stimulation and response recording of the facial
nerve were determined previously as described by Sharma et al. to be 15 mA of
stimulating current given at a frequency of 0.5 Hz; an average of 25 responses was
recorded for each trial (2010b). Trials were repeated at least once to verify consistency
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of the recorded response. Recordings were conducted both on the right and the left
sides, and percent change in amplitude and latency for the right facial nerve, relative to
the left, was analyzed.

3. VOCAL FOLD MOBILITY TESTING
The technique of direct laryngosopy was used to gather vocal fold mobility
(VFM) measurements. After an animal was placed supine in a stereotactic operating
system and the skull secured, a silk suture was used to retract the tongue while a 0°
Pediatric ENDOGO® (Medtronic) operating endoscope with an epiglottis elevator was
inserted into the larynx to observe and record vocal fold movement during respiration.
The nose cone used to deliver isoflurane and oxygen remained over the nose during this
procedure to maintain an appropriate plane of anesthesia. Videos were recorded with the
ENDOGO® at the following points during surgery: pre-crush or pre-electrode placement
(to confirm normal movement before crush), during determination of threshold ES,
immediately post-crush (to confirm lack of mobility), and the day of euthanasia to assess
recovery. Because of the tongue suture required for video capture of VFM, weekly
measurements were not performed on the same set of animals; instead animals were
assigned to a time-point and VFM measurements were only performed on the day of the
crush and the day of euthanasia. This increased the number of groups and subsequently
the number of animals required for the study.
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3. GAIT ANALYSIS WITH CATWALK XT© APPARATUS
The behavioral training regimen for the CatWalk XT consisted of food-depriving
the animals for 12 hours a day, then placing them at one end of the walkway and a yogurt
reward (Stonyfield Organic Strawberry Children’s Yogurt) at the other to encourage the
animal to run across the walkway. The reward was removed as the animal approached
the other end of the walkway and was given to the animal after 3 successful crossings of
the walkway had been achieved.

Training occurred once a day for the 14 days

immediately prior to sciatic nerve injury.
Weekly testing of animals was done using the CatWalk XT apparatus. As during
training, animals were food deprived for 12 hours the day of testing and tested during
their active portion of the light cycle. The same yogurt reward was given to the animal
after a minimum of 3 usable runs were achieved. A usable run had the following
characteristics: at least 3 step cycles were recorded; the speed variability was low (less
than 40%); and, there were no pauses as the animal crossed the walkway.

All usable

runs gathered for a particular animal on a specific day were analyzed and run statistics
combined to create trial statistics; trial statistics were analyzed and compared across
groups at various time points.
The following trial statistics have been shown to change following sciatic nerve
injury and were thus chosen for analysis: base of support, print length, print width, print
area, step pattern preference, and regularity index (Deumens et al 2007). Please see
Figure 11 for visual representations of the parameter definitions. Base-of-support (BOS)
is defined as the distance between paws attached to the same girdle as measured
perpendicular to the walking direction; only the BOS for hind paws is affected by sciatic
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Figure 11. Parameters used to evaluate sciatic function. (A) shows a bottom-up
view of the outline of a rat resting on all 4 paws. The order of paw placement, stride
length, print length, print width, print area, and base-of-support are all measurements
that can be gathered from this view of the animal. The base of support can be
determined for both the shoulder and pelvic girdles and is defined as the distance
between paws attached to the same girdle as measured perpendicular to the walking
direction. (B) shows a single rat paw that has been enlarged.
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Figure 12. Normal Step Sequences. The six step patterns shown above can be
grouped into three pairs: cruciate (an entire girdle is placed on the surface before
the other one), alternate (paws from alternating girdles are placed), and rotary
(circular pattern of paw placement).
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nerve injury. Print length is defined as the length of the box which is artificially placed
around the paw prints by the CatWalk XT software program. Print width is defined
similarly to print length with the substitution of the width of the box for the length. Print
area is the total surface area of the glass floor contacted by the hind paw during the
complete stance duration. Changes in step pattern preference can be determined by
comparing the predominantly used patterns among different animal groups. There are 6
normal step patterns defined for rodents and these can be grouped into the following 3
pairs as shown in Figure 12: cruciate (both paws of the shoulder girdle are placed before
both paws of the pelvic girdle are placed), alternate (one paw from the shoulder girdle is
placed first followed by a paw from the pelvic girdle; this is repeated with the remaining
paws), and rotate (rotary paw placement). Animals that have received a sciatic nerve
transection have been found to change their preferences in step patterns to those that have
the affected hindpaw being preceded by the most distant paw; this keeps the center of
gravity as far away as possible from the affected paw (Deumens et al., 2007). The
regularity index expresses the number of normal step sequence patterns relative to the
total number of paw placements.

H. STATISTICAL ANALYSES
Statistical analyses were performed using the SigmaPlot, Systat, and SPSS
software packages. To determine significant differences between two groups, a two-tailed
Student’s t-test with unequal variances and p < .05 was performed.

To determine

significant differences between three or more groups, a one-way analysis of variance
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(ANOVA), with a Holm-Sidak multiple comparison post-hoc test at p < .05, was
conducted. A two-way ANOVA was done when two independent variables, such as time
and treatment, were present. This statistical test was again followed by a Holm-Sidak
multiple comparisons post-hoc test to determine specific differences among groups.
In experiments where data values in a group did not fall along a normal
distribution, the following non-parametric tests were used: for comparisons between two
groups, the Mann-Whitney U test and for comparisons between 3 or more groups, the
Kruskal-Wallis test with Mann-Whitney U post-hoc tests.
For the RLN experiment in particular, a logistic regression analysis of the
percentage of animals achieving complete recovery was carried out to predict recovery
status using time and treatment as predictors.

This analysis was used because the

outcome, being completely recovered or not, is a binary rather than continuous function.
The resulting odds-ratios determined describe the odds of being completely recovered
with one treatment as compared to the odds of being completely recovered given no
treatment. Chi-squared analyses were subsequently used at individual time points to
examine the predictive value of a treatment based on recovery status and to determine if
there were significant differences between treatments in the likelihood of achieving
complete recovery.

CHAPTER IV
EFFECTS OF ELECTRICAL STIMULATION AND TESTOSTERONE IN
COMBINATION ON FUNCTIONAL RECOVERY FOLLOWING
INTRACRANIAL FACIAL NERVE CRUSH INJURY

A. ABSTRACT
As functional recovery following peripheral nerve injury is dependent upon
successful regeneration and target reconnection, combinatorial treatments that enhance
different regeneration events may be required for recovery from severe injuries. The
neurotherapeutic effects of nerve electrical stimulation and gonadal steroids have been
demonstrated independently and in combination in extratemporal and intratemporal facial
nerve injuries. The purpose of the first aim of this dissertation was two-fold: 1) to
develop a reliable intracranial facial nerve crush model and 2) to investigate the
therapeutic potential of combining ES with gonadal steroids in this most proximal model.
Adult male rats were divided into three experimental groups: intracranial sham-operated,
intracranial crush, and intracranial crush plus ES+TP combination therapy. Animals
were observed daily for return of facial nerve function, including the eyeblink reflex,
vibrissae orientation, and movement. Motor nerve conduction studies were done weekly
to quantify the changes in peak amplitude and latency of evoked response. Rats treated
with the combination therapy recovered partial facial function before untreated rats,
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suggesting that the combination works in tandem to boost regenerative properties.

B. INTRODUCTION
Peripheral nerve lesions are common types of nervous system injuries that often
lead to substandard functional recovery.

Though the peripheral nervous system

motoneurons have a robust ability to regenerate, recovery from nerve injury is dependent
upon cell survival, repair, and mounting of a successful regenerative response. Despite
the availability of surgical repair, complete functional recovery is often hindered by slow
rates of regeneration over long distances and/or inadequate target reconnection (ValeroCabre et al., 2004). Strategies to increase the rate of axonal regeneration and recovery
are thus valuable therapeutic approaches.
The facial nerve in particular has been the subject of much investigation as it is a
commonly injured nerve in humans (Gilden, 2004) and over the years various animal
models have been developed to study the injury response in peripheral motoneurons and
functional recovery. These animal models, which involve crush injuries either distal to
the nerve’s exit from the stylomastoid foramen or throughout its course within the
temporal bone, do not adequately mimic all conditions under which the facial nerve is
subject to injury.

The facial nerve is often compressed by the growth of acoustic

neuromas and other tumors of the cerebellopontine angle or injured when such tumors are
removed from the tiny and hard-to-access area (Mavrikakis, 2008). No animal model
exists to recapitulate such injuries, which is unfortunate as the incidence of such tumors
is increasing in the human population (Edwards et al., 2006).
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It is well known that the more proximal to the cell body that a motoneuron is
injured, the worse the functional outcome and the longer the timeframe for recovery. Our
laboratory has demonstrated this directly by comparing recovery times between animals
receiving extratemporal and intratemporal facial nerve crush injuries; it takes more than
twice as long to begin to recover from the more proximal injury (Sharma et al., 2009a)
Thus, it is important to have models of injuries proximal to the cell body in order to study
the effects of potential therapies on severe injuries. Sharma et al. also found that the
achievement of complete functional recovery from intratemporal facial nerve crush injury
required a combinatorial treatment strategy (2010a) whereas individual treatments yield
significant improvements in recovery from the more distal extratemporal facial nerve
crush.
The combinatorial treatment strategy our laboratory has employed consists of the
systemic administration of the gonadal steroid testosterone propionate and brief electrical
stimulation (ES) of the crushed nerve. Throughout the study of the nervous system,
gonadal steroids have been shown to exert significant trophic effects on the nervous
system, including changes in cell survival, neurotransmitter metabolism, and neuronal
regeneration (Schumacher et al., 1996; De Nicola, 1993; Jones, 1994; Jones, 1993a;
Tetzlaff et al., 2006; Bialek, et al., 2004). Our lab has demonstrated that exogenously
applied testosterone accelerates functional recovery and regeneration rates in hamsters
subjected to extratemporal facial nerve crush as well as in rats subjected to sciatic nerve
crush (Kujawa et al.,1989; Kujawa et al., 1991; Jones, 1993b; Tanzer and Jones, 1997;
Brown et al., 1999). Since gonadal steroids primarily exert their effects on target tissue
using a receptor-mediated mechanism and receptor-mediated mechanisms require
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multiple steps for signal transduction, the therapeutic effects of gonadal steroids may
be delayed in comparison to therapies that can exert more immediate effects.
In contrast, ES has been shown recently to have more immediate effects, as
compared to gonadal steroids (Sharma et al., 2009b; Sharma et al., 2010b). Application
of electrical fields has long been known to affect morphological and functional properties
of neurons, such as nerve branching, rate and orientation of neurite growth, rapid
sprouting, and guidance during axon regeneration (Borgens et al., 1981; Patel and Poo,
1982; Manivannan and Terakawa, 1994; Borgens, 1999). More recently, brief ES of the
rat femoral nerve proximal to the injury site was shown to enhance axonal regeneration
and specificity of motor re-innervation pathways (Al-Majed et al., 2000).

ES also

improves reinnervation and modulates spinal plastic changes following sciatic nerve
injury in rats (Vivo et al., 2008). ES appears to exert these effects by influencing the
neuronal soma response, in part by increasing expression of neurotrophic factors and
their receptors and elevating levels of intracellular messengers such as cAMP soon after
injury (Al-Majed et al., 2000; Al-Majed et al., 2004; Udina et al., 2008).
In the first aim of this dissertation, the effects of a combinatorial treatment
strategy, administering both gonadal steroids and ES, on functional recovery were
investigated in the newly developed intracranial facial nerve axotomy model.

The

rationale for this strategy was that, since the two treatments work through different
mechanisms as well as during different phases of regeneration, then using them in
combination may be required to achieve recovery in an injury model in which
spontaneous recovery is limited. Our previous studies have demonstrated the positive
effects of ES and gonadal steroids, alone and in combination, on functional recovery
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following both extratemporal and intratemporal facial nerve crush injury in rats.
Results from the more distal crush injury show that while either treatment alone
accelerates recovery by ~8%, the combination treatment of electrical stimulation plus TP
shortens recovery time by ~22% compared to untreated animals (Lal et al., 2008; Hetzler
et al., 2008). Results from the intratemporal facial nerve crush injury established that
both treatments are required to achieve complete recovery (Sharma et al., 2010a). In the
present study, to further assess the therapeutic potential of the ES and TP combination,
we used behavioral tests and motor nerve conduction studies following an intracranial
facial nerve crush injury in gonadectomized adult male rats.

C. MATERIALS AND METHODS

1. ANIMALS & NERVE INJURY PARADIGM
Adult male Sprague-Dawley rats, weighing 250g, were purchased from Harlan
(Indianapolis, IN) and used for all experiments, as described in Chapter III. Three to five
days prior to nerve injury, rats were anesthetized with isofluorane and castrated. For
facial nerve axotomy, rats were anesthetized by intra-peritoneal injections of Ketamine
(100mg/ml; 0.1ml/100g body weight) and Xylazine (20mg/ml; 0.025ml/100g body
weight). The right facial nerve was crushed at its exit from the pons as it entered the
internal auditory canal (refer to Chapter III for details). One 60-second crush, was done
with fine jeweler’s forceps to ensure a full crush.
The experimental design for this study is presented in Figure 13. Animals were
divided into 3 experimental groups: [1] sham-operated, animals receiving no axotomy

Sham

3–5 d

Gonadectomy

Intracranial Facial
Nerve Exposure

Crush
+
No Treatment

Daily Functional
Recovery Assessment
Weekly Motor Nerve
Conduction Assessment

Crush
+
ES +TP
12 wk

Figure 13. Experimental Design for Aim 1. This timeline will be followed to examine the effects of the combination treatment on
recovery from intracranial facial nerve crush.
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and no treatment, n = 5 [2] no treatment, animals receiving axotomy but no treatment,
n = 5 [3] ES + TP, animals receiving axotomy and the combination of ES and TP
treatments n = 4.

2. ELECTRICAL STIMULATION
A custom electrode apparatus constructed in our laboratory was used in all rats
(refer to Chapter III). Two Teflon-coated wires, bared of insulation for 2-3mm, were
soldered to two “male” connector pins in a connector strip. At the time of axotomy,
wires were run through subcutaneously and sutured ~2 mm proximal to the injury site
(cathode) and ~3-5mm away from it (anode). The connector pins of rats were attached to
leads of an isolated pulse stimulator, and rats were stimulated at a voltage at which they
displayed a right ear flutter. Immediately post-axotomy, rats were either stimulated with
supramaximal pulses delivered at a frequency of 20 Hz or sham stimulated for 30 min.
Electrode wires were then removed and the animal’s wounds were closed.

3. HORMONE ADMINISTRATION
Immediately

after

injury,

rats

receiving

testosterone

treatment

were

subcutaneously implanted with two Silastic capsules (0.062 in. id x 0.095 in. od; 10-mm
length), equilibrated in physiological saline and containing 100% crystalline TP (refer to
Chapter III for details).

The dosage given has previously been shown to establish

supraphysiological levels of systemic TP (Kujawa et al., 1989; Tanzer and Jones, 2004;
Hetzler et al., 2008).
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4. FUNCTIONAL RECOVERY ASSESSMENT
Recovery of facial function on the right side was compared daily to the intact
function on the left side, as described previously in Chapter III. Animals were observed
for the return of eyeblink reflex and vibrissae orientation and vibrissae movement. For
each of these functional parameters, the recovery time to reach function symmetric to that
on the uninjured side was noted for analysis. For the eyeblink reflex, in addition to its
complete recovery, the time till onset of the blink was also analyzed.

Each group

contained an n of 4-6.

5. ELECTROMYOGRAPHIC RECORDINGS
Motor nerve conduction tests were done as described previously in Chapter III.
Animals were anesthetized with intra-peritoneal injections of Ketamine-Xylazine, and
recordings were taken pre- and post-operatively on the day of axotomy and weekly
thereafter. Two stimulating electrodes were placed below the infraorbital ridge, and two
recording electrodes were placed on the vibrissae pad to record the evoked muscle
activity distal to stimulation. A reference electrode was placed infererior to the external
ear. The facial nerve was stimulated at a frequency of 0.5 Hz and a 15 mA current, and
an average of 25 responses was recorded. Percent change in peak amplitude and latency,
relative to the response on the unoperated side, was calculated and plotted as a function
of weeks post-axotomy. An n of 4-6/time point was used for each of the 3 experimental
groups.
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6. STATISTICAL ANALYSIS
Significant differences in functional recovery parameters between treated and
untreated groups were assessed using the non-parametric Mann-Whitney U test with
p<0.05. To determine statistical significance among groups for percent change in
amplitude and latency a two-way ANOVA (factors = dpo and treatment) was performed.
Furthermore, it was decided a priori to compare the untreated and treated animals at the
endpoint of the study, 12 wpo.

D. RESULTS

1.

DIFFERENCES IN FUNCTIONAL RECOVERY FOLLOWING TREATMENT

WITH ES+TP COMBINATORIAL THERAPY
Figure 14 demonstrates the effects of the combinatorial therapy of ES+TP on the
timing of the onset and full recovery of the facial functional parameters that returned
throughout the time course of the study. Administration of the combination therapy
significantly accelerated the onset of the eyeblink reflex as compared to no treatment
(16.5 ± 0.3 dpo and 19.2 ± 1.0 dpo, respectively; p < .05). Recovery time of the full
eyeblink reflex was dramatically shortened in the group that received treatment. None of
the untreated animals recovered the full reflex by 84 dpo, whereas all of the animals that
had received the combination treatment recovered within the time frame of the study, 12
weeks. An alternative way to analyze these data, though highly conservative, would be
to label all of the animals that exhibited an incomplete eyeblink reflex at the end of the
study as being recovered at 84 dpo. Even this conservative approximation of recovery
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Figure 14. Effects of brief ES and TP on onset and complete return of facial
functional parameters following an intracranial facial nerve crush injury.
Shown are recovery times in individual animals for the onset of the eyeblink reflex
(Semi-Eyeblink), return of the complete eyeblink reflex, the onset of vibrissae
movement, and return of the complete vibrissae orientation following administration
of the combinatorial treatment of ES+TP or no treatment. As animals were followed
for a maximum of 84 dpo, the asterisk over the complete eyeblink parameter
indicates that all of the untreated animals experienced incomplete return of the
eyeblink reflex. † = p < .05 comparing treated and untreated animals. n = 4-5/group.
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time yields statistical significance when comparing the untreated and treated animals
(treated animal recovery time of 76 ± 1.2 dpo), highlighting the powerful effects of ES
and TP in combination.
Vibrissae orientation returned in untreated animals at 58.6 ± 1.7 dpo. It returned
at 50.2 ± 1.2 dpo in treated animals indicating there was a trend toward decreasing
recovery times with the addition of the combination treatment. Though this decrease did
not achieve statistical significance, it came close with p = 0.065 and was probably due to
the larger variability among untreated animals; it is also important to note that all of
animals in the combinatorial treatment group recovered vibrissae orientation before the
earliest animal in the untreated group, indicating this parameter is being positively
affected by treatment.
Since complete vibrissae movement is the last facial functional parameter to
return, the recovery time for vibrissae movement also determines the time for complete
recovery. Unfortunately none of the animals in the study recovered completely within 84
days; however, there were significant differences between treated and untreated animals
in the onset of the recovery of this parameter. In untreated animals, the vibrissae began
to move at 46.6 ± 4.2 dpo. Administration of ES plus TP significantly reduced the time
to begin movement to 23.5 ± 0.4 dpo.

2.
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EFFECTS OF TREATMENT WITH ES AND TP ON MOTOR NERVE

CONDUCTION
Motor nerve conduction studies were performed weekly following axotomy and
treatment with the combination therapy of ES and TP. Figure 15 demonstrates the
percent change in peak amplitude of the evoked response for the crushed facial nerve in
animals receiving no treatmentand the combination of ES plus TP. Following axotomy at
1 wpo, peak amplitude dropped to -80-90% in both groups that were injured. The
amplitude was slightly decreased from baseline in sham animals, but this was not
significant. By 12 wpo, peak amplitude in untreated animals remained significantly
below normal. In comparison, in animals receiving the combined treatment of ES plus
TP, the peak amplitude levels returned to near normal baseline values (-6.8 ± 28.5%) at
12 wpo (p < .05).
Figure 16 demonstrates the percent change in latency of the evoked response for
the crushed facial nerve in animals receiving no treatment or the combination of ES plus
TP. Following axotomy, at 1 wpo, latency of response increased by ~35-45% in all
animals. Over the 12 weeks of the study, the latency gradually decreased and reached
baseline/sham levels, ~5-10%, by 12 wpo. There was no difference in latency between
the treatment groups; both remained elevated for the first 7 weeks post-injury and began
to decline toward baseline starting around 8 wpo.
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Figure 15. Effects of brief ES and TP on peak amplitude of evoked response
following following an intracranial facial nerve crush injury. Motor nerve
conduction testing was done to record peak amplitude of the evoked response in the
vibrissal pad upon facial nerve stimulation. Shown are percent changes in peak
amplitude on the injured side, relative to the unoperated side, over a time course.
Vertical lines represent standard error of the mean. * = p < .05, comparing untreated
and treated animals at a particular time point. Dotted red line at y-intercept
represents baseline. n = 4-5/group.
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Figure 16. Effects of brief ES and TP on latency of evoked response
following an intracranial facial nerve crush injury. Motor nerve conduction
testing was done to record latency of the evoked response in the vibrissal pad
upon facial nerve stimulation. Shown are percent changes in latency on the
injured side, relative to the unoperated side, over a time course. Vertical lines
represent standard error of the mean. n = 4-5/group.

71
E. DISCUSSION
The present study found that the administration of a combination of ES and
testosterone exerted positive effects on functional recovery from an intracranial facial
nerve crush. Though the acceleration of complete recovery was not observed in any of
the animals by the end of the 12 week time frame, it is possible that had the study been
extended further complete recovery could have been achieved by the animals. The
possibility also exists that complete recovery from this type of injury can never be
realized. In that light, the benefits seen in the parameters indicative of partial functional
recovery demonstrate the benefit of this combinatorial treatment. Since recovery from
this proximal injury is protracted just as in human recovery from facial nerve palsy, any
return of function brought about by this combination therapy – however little – is
important as it gives hope to patients who have severe peripheral nerve injuries.
Investigators have described the uneven process of axonal regeneration across a
transection and surgical repair site to be patchy as the axons cross the injury site at
different rates and branch repeatedly before finding their way (Brushart et al., 2002; AlMajed et al., 2000a). Since it has been shown that ES, when administered alone, does not
promote the return of the normal evoked facial nerve response following intratemporal
injury and does not yield complete recovery (Sharma et al., 2010a), ES is likely effective
in amplifying the initial regeneration response but cannot sustain it. Testosterone, on the
other hand, can accelerate the rate of regeneration as well as prevent atrophy of target
muscles; its actions complement the actions of ES by sustaining the upregulated
regeneration response through continued upregulation of genes associated with
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regeneration (Sharma et al., 2009b; Sharma et al, 2010b). The effectiveness of the
combinatorial treatment of ES and testosterone in accelerating functional recovery and
the return of more normal motor nerve conduction may be explained by faster regrowth
across the crush site, mediated by ES, in addition to a sustained enhanced regenerative
response, mediated by TP. These findings have direct clinical relevance for cases of
proximal intracranial facial nerve injury in which functional recovery is significantly
prolonged.

CHAPTER V
EFFECTS OF ELECTRICAL STIMULATION AND TESTOSTERONE ON
FUNCTIONAL RECOVERY FOLLOWING RECURRENT LARYNGEAL
NERVE INJURY

A. ABSTRACT
Because suboptimal functional recovery often occurs following peripheral nerve,
it may be valuable to employ therapies that enhance the intrinsic ability to neurons to
regenerate. Using the injury paradigm of intrcranial facial nerve crush, our previous
study investigated the effects of a combinatorial treatment strategy, consisting of ES of
the proximal nerve stump and systemic TP administration in Aim 1. Results indicated
that the combination improves functional recovery. To begin to determine the
generalizability of this treatment strategy, the second aim of this dissertation investigated
the effects of ES and TP on recovery from a recurrent laryngeal nerve (RLN) crush.
Following a left RLN crush at the level of the 7th tracheal ring, gonadectomized adult
male rats were administered only ES, only TP, a combination of both, or left untreated
and vocal fold mobility was assessed weekly.

The two treatments were found to

accelerate

well

recovery

individually

as
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as

in

combination.
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B. INTRODUCTION
The RLN follows a long and indirect course from where it branches off the Vagus
nerve to its laryngeal entry. Its passage through the thorax and course through the thyroid
gland make it particularly vulnerable to damage during surgery involving the neck or
thorax. RLN lesions result in significant patient morbidity, causing vocal fold paralysis
and incomplete glottic closure which can lead to changes in vocal pitch or a lack of voice,
dysphonia, dysphagia, and in some cases aspiration (Araki et al., 2005; Tessema et al.,
2009). The effects of these symptoms on patient quality of life can be devastating and
recovery from this type of injury is variable and dependent on the degree of the initial
damage; some patients recovery spontaneously within weeks while others never do
(Myssiorek, 2004; Rosenthal et al., 2007). Current treatments focus on medialization of
the injured vocal fold through injection of collagen but do not address the lack of
mobility (Rubin et al., 2003).

Intraoperative monitoring of nerve conductivity is

standard procedure in operating rooms during surgeries that put the RLN at risk;
however, this has only been used as a pre-emptive measure.

Previous work has

demonstrated that a combination treatment consisting of brief electrical stimulation (ES)
and supraphysiologic levels of testosterone, a gonadal steroid, improves functional
recovery from both extratemporal and intratemporal facial nerve injury in rats (Hetzler et
al., 2008; Sharma et al., 2010b) and from intracranial injury as shown in Aim 1. If this
combination treatment proves to be effective in a second nerve injury model, it would
provide more evidence for its potential use over a spectrum of human peripheral nerve
injuries.
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Electrical stimulation (ES) of injured nerves is associated with enhanced
regeneration and thus it would be valuable to explore the translational potential of ES to
RLN injury (Gordon et al., 2008). A summary of ES-mediated neuronal effects includes
neuronal excitation, upregulation of regeneration-associated gene expression, promoting
neurite growth after injury, improving selective targeting of regenerating axons,
providing alignment and polarity instructions to myelinating Schwann cells, and
enhancing the functional recovery of target organs (Gordon et al., 2008; Wan et al.,
2010). Gonadal steroid hormones have also been explored as neurotherapeutic agents
and have been shown to play trophic and protective role in conditions of injury or disease
(Fargo et al., 2008). As gonadal steroids and ES may target regeneration events through
different mechanisms or during different phases, combining both of these treatment
strategies may be advantageous.
ES can be applied to a variety of places along the path of conduction. Target
muscles innervated by the injured nerve can be stimulated or the neuron itself can be
stimulated either distal or proximal to the injury site. End-organ stimulation has been
clinically useful because it is a substitute for the usual neuronal input and thus keeps the
denervated muscle alive while the injured axons are regenerating; however, it does not
stimulate axonal regrowth itself (Williams, 1996). Stimulation to the injured nerve itself
sends impulses in the forward direction along the myelin sheath as well as backwards
toward the cell body to augment the internal distress signals carried by reverse axonal
transport that increase expression of regeneration-associated genes such as growthassociated protein-43 (GAP-43; present at the tips of growth cones), α1-tubulin (a
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structural protein within axons), brain-derived neurotrophic factor (BDNF), neuritin
(enhances neurite extention in vitro), and pituitary adenylate cyclase-activating peptide
(PACAP) (Sharma et al 2010b).
In addition to effecting change when applied at different points along the neuronal
conduction path, ES can be applied either once or multiple times within a wide range of
safe stimulation parameters. In terms of clinical relevance, patients are much more likely
to be compliant with a one-time application versus having to come back to clinic for
multiple follow-up visits and both animal as well as human data indicate that one-time
stimulation is at least as effective, if not more so, than frequent stimulations (Al-Majed et
al., 2000; Gordon et al., 2009; Sharma et al., 2010a). ES treatment affects “early” events
during regenerations: it reduces the initial delay before sprout formation begins, fails to
accelerate the overall regeneration rate, and leads to rapid but short-term upregulation of
regeneration-associated genes (Sharma et al., 2009b; Sharma et al., 2010b). Thus, the
positive effects of ES on recovery have often been observed soon after treatment.
Testosterone, on the other hand, has been shown to accelerate the axonal
regeneration rate through upregulation of genes involved in producing the structural
building blocks of axons (including the tubulins) and leads to delayed but long-term
upregulation of other regeneration-associated genes (Sharma et al., 2009b; Sharma et al.,
2010b; Jones and Oblinger, 1994). We have previously combined this delayed effect of
testosterone, using testosterone propionate (TP) which is a long-lasting form, with the
more-rapidly acting ES to yield positive recovery results in facial nerve injury models
(Hetzler et al., 2008; Sharma et al., 2010a). It is additionally important to note that the
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RLN is similar to the facial nerve in that both cranial nerve nuclei from which the two
nerves arise are abundant in androgen receptors (the nucleus ambiguus and the facial
motor nucleus, respectively) (Perez and Kelley, 1996; Yu and McGinnis, 2001) and thus
may be similarly sensitive to androgen treatment. However, cancers of the neck and
throat are typically androgen-receptor negative (Voelter et al., 2008; Hagedorn and
Nerlich, 2002) – an important factor to consider when it is often the removal of these
cancers during which the RLN is injured.
It has been previously demonstrated that the natural timecourse for recovery from
an RLN crush injury is up to 6 weeks (Tessema et al., 2009). The aim of the present
study was two-fold: 1) to develop a model for therapeutic application of ES to an injured
RLN; 2) to compare the effects of individual ES and testosterone treatments and the
combination on functional recovery thereby adding generality to the efficacy of the
combination treatment.

Brief ES and TP were administered either alone or in

combination and vocal fold mobility was assessed at different time-points in different
groups of rats between 1 and 4 weeks post-operative (wpo).

C. MATERIALS AND METHODS

1. ANIMALS & NERVE INJURY PARADIGM
Adult male Sprague-Dawley rats (~2 months old) were purchased from Harlan
(Indianapolis, IN) and used for all experiments, as described in Chapter III. Three to five
days prior to nerve injury, rats were anesthetized with isofluorane and castrated. For
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RLN crush axotomies as well as vocal fold mobility assessments, rats were
anesthetized with isofluorane and breathing rate was monitored continuously during
procedures. The left RLN was crushed at the level of the 7th tracheal ring, as described
previously in Chapter III. Two successive 30-second crushes, on alternating sides, were
done with fine jeweler’s forceps to ensure a full crush.
The experimental design for this study is illustrated in Figure 17. Animals were
divided into 4 experimental groups: [1] no treatment, animals receiving axotomy but no
treatment, [2] ES only, animals receiving axotomy and ES treatment, [3] TP only,
animals receiving axotomy and TP treatment, and [4] ES + TP, animals receiving
axotomy and the combination of ES and TP treatments.

2. ELECTRICAL STIMULATION
A custom electrode apparatus constructed in our laboratory was used in all rats
(refer to Chapter III). Two Teflon-coated wires, bared of insulation for 2-3mm, were
soldered to two “male” connector pins in a connector strip. At the time of axotomy,
wires were bent around the freed left RLN in place between the 5th and 9th tracheal rings
(cathode) and sutured ~3-5mm away from the injury site (anode). The connector pins of
rats were attached to leads of an isolated pulse stimulator, and rats were stimulated at a
voltage at which they displayed flutter of the left vocal fold. Immediately post-axotomy,
rats were either stimulated with supramaximal pulses delivered at a frequency of 20 Hz or
sham stimulated for 30 min.

1 wpo

No Treatment
2 wpo
ES
3–5 d

Gonadectomy

TP

3 wpo

ES +TP
4 wpo

Recurrent Laryngeal
Nerve Crush

1. VFM Assessment via
Direct Laryngoscopy
2. Euthanize animal

Figure 17. Experimental Design for Aim 2. This timeline will be followed to examine the effects of ES and TP on recovery from
recurrent laryngeal nerve (RLN) crush. Untreated animals will be observed at 5 and 6 weeks in addition to the other time points.
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3. HORMONE ADMINISTRATION
Immediately following injury, two Silastic capsules (0.062 in. id x 0.095 in. od;
10-mm length), equilibrated in physiological saline and containing 100% crystalline TP
(Sigma), were subcutaneously implanted in rats receiving hormone treatment.

The

dosage given has previously been shown to establish supraphysiological levels of
systemic TP (Kujawa et al., 1989; Hetzler et al., 2008; Tanzer and Jones, 2004).

4. VOCAL FOLD MOBILITY ASSESSMENTS
Direct laryngoscopy was achieved with a pediatric ENDOGO® and a usermodified sheath as described in Chapter III. Because of the tongue suture required for
video capture of vocal fold mobility (VFM), weekly measurements were not performed
on the same animals; instead animals were assigned to a time-point and VFM
measurements were only performed on the day of the crush and the day of euthanasia.
This increased the number of groups and subsequently the number of animals required
for the study.
Recovery of vocal fold mobility on the left side was compared to the intact
function on the right side. Paralysis was defined as the inability of the laryngeal muscle
to abduct the affected side of the vocal fold. Videos were block-randomized, blinded,
and scored by trained observers. An integral scoring scale of 0-4 was used.

81
5. STATISTICAL ANALYSIS
Significant differences in vocal fold motion among the various treatment groups
were assessed using a two-way ANOVA (treatment x time) followed by the Holm-Sidak
post-hoc test at p < .05 to examine the relationship between treatment and time on VFM
scores.
A logarithmic regression analysis of the percentage of animals achieving
complete recovery was carried out to predict recovery status using time and treatment as
predictors (SPSS). Chi-squared analyses were subsequently used at individual time points
to examine the predictive value of a treatment based on recovery status and to determine
if there were significant differences between treatments in the likelihood of achieving
complete recovery.

D. RESULTS

1.

DIFFERENCES IN FUNCTIONAL RECOVERY FOLLOWING TREATMENT

WITH ES, AND/OR TP
Figure 18 demonstrates the effects of ES alone on the timing of the recovery of
vocal fold motion. Administration of brief ES significantly accelerated VFM recovery as
compared to no treatment at one and two weeks post-crush (Average VFM = 0.5 and
Average VFM = 2 at 1 wpo, respectively; p<0.01; average VFM = 2.25 and Average
VFM = 3.67 at 2 wpo, respectively; p<0.05; Figure 18). However, as all animals were
reaching the ceiling of full recovery by 3 and 4 weeks, this difference was no longer
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Figure 18. Effects of brief electrical stimulation (ES) on vocal fold mobility
(VFM) following a recurrent laryngeal nerve (RLN) crush injury. Shown are the
average VFM scores at 1, 2, 3, and 4 weeks after RLN crush injury (WPO)
comparing Untreated (CTL) and ES-treated animals. Each bar represents a separate
cohort of animals. Vertical lines represent standard error of the mean. (** = p < .01,
relative to no treatment; * = p < .05, relative to no treatment). n = 4-8/group..
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Figure 19. Effects of brief electrical stimulation (ES), and/or supraphysiological
testosterone propionate (TP) on vocal fold mobility (VFM) following a recurrent
laryngeal nerve (RLN) crush injury. Shown are average VFM scores for 1, 2, 3, 4,
5, and 6 weeks after RLN crush injury (WPO) comparing all treatments. Vertical
lines represent standard error of the mean. (** = p < .01, each treatment compared to
no treatment; * = p < .01, ES and ES+TP treatments compared to no treatment). n =
4-9/group. Each time point represents a separate cohort of animals.
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significant at these time points. Figure 19 demonstrates the effects of ES and/or TP on
the timing of the recovery of vocal fold motion.

TP administration by itself also

produced increased VFM scores at 1 and 2 weeks post-crush as compared to controls, but
there were no statistical differences between the ES-treated and TP-treated animals.
(Average VFM for TP treatment = 1.9 and 3.4 at 1 and 2 wpo, respectively). Adding ES
and TP produced the largest significant increase in average VFM at the early time-point
of 1 week post-operative as compared to untreated animals (Average VFM = 0.5 and
Average VFM = 2.4 at 1 wpo, respectively; p<0.05; Figure 19).
Vocal fold mobility scores were significantly increased in all treatment groups
relative to the untreated group at 1 and 2 wpo. These differences became non-significant
by week 3 as the untreated animals’ VFM scores began to move closer toward the upper
limit of complete recovery. Within the untreated group, completely recovered animals
began to be seen only at 3 wpo, whereas in the treatment groups fully recovered animals
were seen as early as 1 wpo. The Two-way ANOVA with Holm-Sidak post-hoc tests
revealed a statistically significant effect of treatment [F(3, 80) = 6.57, p < .001] and a
statistically significant effect of time [F(3, 80) = 35.37, p < .001]. No statistically
significant interaction was observed between time and treatment [F(9, 80) = .90, n.s.].
Table 1 breaks down the percentage of animals within each treatment group that
did or did not attain complete RLN functional recovery at each time point. It required 6
weeks for all animals in the untreated group to recover which is consistent with
previously published literature (Tessema et al 2007). The application of all treatments
(TP, ES, or ES+TP) significantly decreases the time to recovery of vocal fold mobility

0 (0/4)
14 (1/7)
25 (2/8)
11 (1/9)

Untreated
TP
ES
ES+TP

0 (0/4)
60 (3/5)
67 (4/6)
67 (4/6)

2
40 (2/5)
80 (4/5)
86 (6/7)
67 (4/6)

3
50 (2/4)
100 (6/6)
100 (6/6)
100 (8/8)

4

80 (4/5)

5

100 (6/6)

6

Table 1. Effects of brief electrical stimulation (ES), and/or supraphysiological testosterone
propionate (TP) treatment on time required to complete functional recovery after recurrent
laryngeal nerve (RLN) crush injury. Shown are the percentages of animals in each group that achieved
a vocal fold mobility score of 4 (defined as complete functional recovery) at 1, 2, 3, 4, 5, and 6 weeks
after RLN crush injury comparing Untreated, TP-treated, ES-treated, and ES+TP-treated animals. Listed
below each percentage in parentheses is the number of recovered animals out of the entire set at each
particular time point (n = 4-9/group). Each time point represents a separate cohort of animals.

1

Treatment
Group

Weeks Post Operative

Percentage of animals achieving complete functional recovery following a RLN crush
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from a RLN crush by two weeks which equates to a 33% reduction in overall recovery
time. Unlike the treated animals, none of the untreated animals achieved complete
recovery within the first two wpo. The logarithmic regression analysis was conducted to
predict recovery status using time and treatments as predictors. A test of the full model
against a constant-only model was statistically significant, indicating that receiving a
treatment increased the odds of attaining full recovery (Chi square = 53.358, p < .0005
with df = 2). This corroborates the previously described result that VFM scores were
higher among the treated animals at the earlier time points. Nagelkerke’s R2 of .571
indicated a moderately strong relationship between prediction and grouping. Prediction
success overall was 79.2% (76.7% for incomplete recovery and 81.1% for complete
recovery) and improved from an initial 55.2%. The Wald criterion demonstrated that
time, ES-treatment, TP-treatment, and ES+TP-treatment each made a significant
contribution to prediction (p < .0005, p = .001, p = .004, and p = .003, respectively).
EXP(B) values (odds ratios) for these parameters were 5.3 (wpo), 28.8 (ES-treatment),
15.6 (TP-treatment), and 18.7 (ES+TP-treatment), respectively.

For example, this

implies that the odds of an ES-treated animal being completely recovered at a particular
time point are 28.8 times higher than if the animal is untreated.

The Chi-squared

analyses of cross-tabulations were performed to compare the treatments to each other and
were not significant, suggesting that all treatments yielded similar results.
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E. DISCUSSION
The present study found that administration of monotherapy of ES and the
combination of ES and TP both had similar effects on functional recovery. ES alone
accelerated the VFM functional recovery parameter and was sufficient to improve
complete functional recovery as compared to untreated animals. In contrast to previous
studies in the facial nerve, the combination of ES and testosterone in the RLN crush
injury model, however, did not significantly shorten the time until complete functional
recovery more than individual treatment.

Though the benefit of a combinatorial

treatment approach was not demonstrated in this model, this could be due to a few
factors. One difference which could account for this is the particular nerve injured.
Though both the facial nerve and recurrent laryngeal nerve derive from cranial
motoneurons, the RLN is a branch of the vagus nerve – a nerve with numerous functions
– whereas the facial nerve is completely motor after it exits the facial canal.

The

polyvagal theory has suggested that the myelinated and unmyelinated portions of the
nerve serve different functions for neurogenic control of the heart (Porges, 2009). Since
the heart is extremely sensitive to electrical activity, the vagal neurons and fibers that
eventually compose the RLN may be more responsive to electrical stimulation as a
therapy. This could account for the seeming lack of improvement with the addition of TP
to the treatment regimen that is necessary in studies of regeneration of the facial nerve
(Sharma et al., 2010a). Additionally, the distance to regenerate in the RLN model is
almost twice as short as that required in an extratemporal facial nerve crush (the most
distal crush our laboratory has examined). If the required regeneration distance is short,
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to a certain degree maximal acceleration of regeneration may be achieved by one
therapy alone and thus no extra benefit is seen by combining two effective treatments.
Electrical stimulation of many varieties has been demonstrated to accelerate
behavioral recovery from facial and hindlimb paralysis after injury to the facial, femoral,
and sciatic nerves (Al-Majed et al., 2000; Hetzler et al., 2008; Gordon et al., 2009); and,
direct stimulation of the injured nerve stump has been shown to decrease the delay in
axonal sprouting post-injury as well as upregulate the regeneration-associated genes
GAP-43, α1-tubulin, BDNF, PACAP, and neuritin to enhance regeneration (Sharma et
al., 2009b; Sharma et al., 2010b). Furthermore, this treatment would be easily applied in
a surgery setting as a stimulator could be easily connected to the intraoperative monitors
used to detect nerve damage during neck and thoracic operations. If nerve damage is
noted, the stimulation could be applied while the patient is still under anesthesia. The
downsides to a subsequent increase in operative time would be more than compensated
for by the potential for improved speech, swallowing, and breathing outcomes with the
use of ES therapy. Additionally, though the 30-min duration of stimulation has been
shown to be effective in this study using the RLN and in others using the facial nerve,
shorter periods have not be examined and it is entirely possible that less time may be
required to see positive results in humans.
Gradual recovery in VFM after unilateral RLN crush injury was observed over a
period of 6 weeks in untreated animals and 4 weeks in treated animals. The untreated
animals recovered along a similar time course to that observed in other studies using a
unilateral crush injury (Araki et al., 2005; Tessema et al., 2008; Tessema et al., 2009).
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Tessema et al noted moderate recovery by 3 wpo (2008) with full recovery by 6 weeks
post-operative. Our observation that none of the animals in the 2 wpo time point had
recovered and only half of the animals had completely recovered at the 4 wpo time point
confirms others reports (Araki et al., 2005; Shiotani et al., 2007).
It is also important to be aware of the relative differences in the distances that
RLN motoneurons must regenerate their axons in humans versus rats when interpreting
the results of the acceleration of behavioral recovery (both initiation and complete). Both
human and rat nerve regeneration rates are in the same order of magnitude,
approximately 1.7 mm/day in humans (Sunderland, 1947) and 4 mm/day in rats (Kujawa
et al., 1993; Wang et al., 1997); however, the distance that a RLN motoneuron in a rat
must regenerate its axon is on the order of millimeters whereas the same injury in a
human will require the RLN motoneuron to regenerate centimeters of axon. Given this
data, it is possible that humans will respond differently and will require the combination
treatment to achieve more complete recovery because their RLN injuries are
comparatively more severe than those delivered to the rats in this pre-clinical study.

CHAPTER VI
EFFECTS OF ELECTRICAL STIMULATION AND TESTOSTERONE IN
COMBINATION ON FUNCTIONAL RECOVERY FOLLOWING SCIATIC
NERVE CRUSH AS COMPARED TO SCIATIC NERVE TRANSECTIONSURGICAL REPAIR (AUTOGRAFT) INJURY

A. ABSTRACT
Injuries to the sciatic nerve can be caused by a vast array of etiologies; however,
no matter the manner of injury, if it is severe enough the functional outcome will likely
be poor. Differing types of injury have disparate associated management strategies based
on the whether or not the injury is lacerating, clean, acute, or chronic. The purpose of the
third aim of this dissertation was to further assess the effects of the combination therapy
by comparing functional recovery in two types of injury to the sciatic nerve with or
without ES plus TP. The sciatic crush injury was compared to a surgery mimicking a
nerve graft procedure of the sciatic nerve (an autograft: a double transection-repair).
Adult male rats were divided into four experimental groups: sciatic crush, sciatic crush
with ES+TP treatment, sciatic transection-repair (autograft), and autograft with ES+TP.
Animals’ gaits were observed with the CatWalk system at 2, 4, 8, and 16 weeks postoperative (wpo). Rats treated with the combination therapy recovered partial function
earlier than untreated rats in both injury paradigms.
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B. INTRODUCTION
Due to its extreme length, the sciatic nerve is subject to many insults. Sciatic
nerve lesions are common clinical conditions that result in significant distortion of
patients gait, stance, and balance. Although function may return completely in some
patients, others may demonstrate delayed recovery or residual deficits. Unsatisfactory
recovery may be due to significant neuronal loss, inadequate reinnervation, misdirection
of regenerating axons, or denervation-induced target atrophy.
As the nerve is formed within the lumbar plexus, it may be injured through
compression by the overlying piriformis; this is known as piriformis syndrome. The
sciatic nerve runs close to the femur as it extends down the thigh, so it can be severed or
crushed when the femur is broken. When the sciatic nerve enters the popliteal fossa, its
common peroneal and tibial branches separate and occupy relatively superficial locations
in the knee region which render it vulnerable to mechanical insults including battlefield
and gunshot injuries. Though the neuromuscular physical exam performed by physicians
and nerve conduction studies can localize the majority of injuries to the sciatic nerve in
humans and document functional recovery, complicated tools for gait analysis must be
used in addition to study recovery from injury in animals (Derr et al., 2009; Masakado et
al., 2008).
Current treatments for sciatic nerve paralysis following transection injuries
include direct anastomosis or cable grafting (Kim et al., 2004). Additionally, ES and TP
have been shown to have positive effects individually on both the experimental sciatic
crush and the more clinically relevant transection-repair injury that closely mimics the
insertion of a nerve graft (Brown et al., 1999; Brushart et al., 2002; Alrashdan et al.,
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2010). However, many patients have incomplete recovery and experience long-term
sequelae from the paralysis.

Therefore, the third aim of this dissertation aimed to

compare the effects of the combination therapy on functional recovery between the wellestablished sciatic crush injury and the transection(s) with repair(s) sciatic injury. Our
findings demonstrated significant differences in recovery sciatic function among injury
types and treatments.

B. MATERIALS AND METHODS

1. ANIMALS
Adult male Sprague-Dawley rats (~2 months old) were purchased from Harlan
(Indianapolis, IN) and used for all experiments, as described in Chapter III. For sciatic
nerve injuries, rats were anesthetized with isoflurane. The experimental design for this
study is illustrated in Figure 20. Animals were divided into four experimental groups
based on the type of sciatic nerve injury and therapy administered: 1) sciatic nerve crush,
no treatment; 2) sciatic nerve crush, ES+TP; 3) sciatic nerve autograft (double transection
and repair), no treatment; and, 4) sciatic nerve autograft, ES+TP.

14 d

Double
Sciatic
Transection
and Repair

No Treatment

(Autograft)

ES +TP

2w

No Treatment

Begin Daily
Training on
CatWalk ™
Apparatus

8w

Gait Assessment via
CatWalk™

3–5 d

Gonadectomy

4w

2w

4w

Sciatic Crush
ES +TP
8w

16w

Euthanize
animal

Euthanize
animal

Figure 20. Experimental Design for Aim 3. This timeline will be followed to examine the effects of the combination treatment on
recovery from sciatic nerve crush and sciatic nerve autograft.
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2. SCIATIC NERVE CRUSH INJURY
A gluteal incision was made, and the right sciatic nerve was exposed using an
approach along the grain of the biceps femoris (refer to Chapter III for details). At
approximately mid-thigh, before branching of the main trunk into common peroneal and
tibial nerves, the sciatic nerve was crushed with jeweler’s forceps twice for 30 sec each
on either side as with the other crushes. The standard crush performed ensured that all
nerve fibers were crushed while the axonal sheath remained intact. In all animals, the left
sciatic nerve was left intact to serve as an internal control. The post-operative survival
time was 8 weeks for animals who received crush injury.

3. SCIATIC NERVE AUTOGRAFT INJURY
The surgical procedure is described in detail in Chapter III. A 2 cm segment of
the right sciatic nerve was exposed along its distal course. The nerve was transected at
two points along the nerve, 7 mm apart, and then the epineurium was reattached with
microsuture. In all animals, the left sciatic nerve was left intact to serve as an internal
control. The post-operative survival time was 16 weeks for animals who received the
transection and repair injury.
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4. ELECTRICAL STIMULATION
A custom electrode apparatus constructed in our laboratory was used in all rats
(refer to Chapter III). Two Teflon-coated wires, bared of insulation for 2-3mm, were
soldered to two “male” connector pins in a connector strip. At the time of axotomy, the
cathode wire was bent around the circumference of the right sciatic in place proximal to
the injury site and the anode was sutured ~3-5mm away in the biceps femoris. The
connector pins of rats were attached to leads of an isolated pulse stimulator, and rats were
stimulated at a voltage at which they displayed twitching of the right hind limb.
Immediately post-axotomy, rats were either stimulated with supramaximal pulses
delivered at a frequency of 20 Hz or sham stimulated for 30 min.

5. HORMONE ADMINISTRATION
Immediately following injury, two Silastic capsules (0.062 in. id x 0.095 in. od;
10-mm length), equilibrated in physiological saline and containing 100% crystalline TP
(Sigma), were subcutaneously implanted in rats receiving hormone treatment (refer to
Chapter III).

The dosage given has previously been shown to establish

supraphysiological levels of systemic TP (Kujawa et al., 1989; Hetzler et al., 2008;
Tanzer and Jones, 2004).

6. FUNCTIONAL RECOVERY ASSESSMENT – CATWALK GAIT ANALYSIS
Rats were trained once a day for two weeks prior to injury to traverse the lighted
walkway of the CatWalk ™ gait analysis apparatus at least three times in a row (refer to
Chapter III). Recovery of sciatic function on the right side was compared weekly to the
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intact function on the left side and the following parameters were analyzed: base of
support, print length, print width, print area, step pattern preference, and regularity index.
Each group contained an n of 5-6.

7. STATISTICAL ANALYSIS
Significant differences among the four experimental groups were determined
using a two-way ANOVA (factors = days post-axotomy and treatment), followed by a
Holm-Sidak post-hoc test at p < .05.

D. RESULTS

1.

DIFFERENCES IN FUNCTIONAL RECOVERY FOLLOWING TREATMENT

WITH ES+TP COMBINATORIAL THERAPY AFTER SCIATIC CRUSH
Figure 21 demonstrates the effect of the combinatorial therapy of ES+TP on hind
paw length. In A there is a trend towards increased paw length on the injured side among
treated animals as compared to those that were untreated. Though these differences over
time did not reach significance, they do suggest that the combination treatment may have
a positive effect on repair. The print length is increased at the 2 week time point relative
to the 4 and 8 week time points for both treated and untreated animals; this is due to heel
walking, an adaptation rats will use when their paw will not support weight. Normally
the heel does not impact the walking surface unless a rat is sitting. The use of this
adaptation can make it difficult to detect treatment effects at the earlier time points as
seen in Figure 21A. Absent heel-walking, the injured hind paw length generally
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A

Control (L)

Axotomy (R)

No treatment
ES+TP

Table 2. Symbol Legend for Aim 3. For viewing consistency, the following labeling
scheme has been used: open symbols indicate no treatment, closed symbols indicate
treatment, triangles indicate the control side (also referred to as the unaxotomized or
left side), and circles indicate the side undergoing axotomy (also referred to as the
axotomized or right side). For parameters that take both control and axotomized sides
into account, including base of support and step pattern frequency, squares are used.
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A

ES+TP
Untreated

B

ES+TP
Untreated

Figure 21. Effects of brief ES and TP on hind paw length
following a sciatic crush injury. Behavioral testing with the
CatWalk™ apparatus was done to record paw print length during
walking after injury. Shown are the print lengths of the injured right
hind paw (A) and the contralateral uninjured left hind paw (B).
Vertical lines represent standard error of the mean. n = 6/group.
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increases over time, which is noted at weeks 4 and 8 post-operative. The uninjured
paw length does not change appreciably in either treated or untreated animals over time.
Figure 22 shows the upward trajectory in injured paw width in animals over time.
Animals that received ES+TP have increased measurements as compared to untreated
animals at 2 and 8 weeks post-operative. There are no changes over time between
untreated and treated animals in the uninjured paw; the line is relatively flat near 20 mm.
By 8 weeks, the injured paw length of treated animals has increased to 17.4 ± .5 mm,
nearly 85% of the uninjured side, whereas the untreated animals have a paw length of
only 16.0 ± .8 mm (78%; p < .05 relative to no treatment). These differences are
highlighted in Table 3.
Figure 23 illustrates the effect of treatment on hind paw area. The injured hind
paw area in untreated animals increases over time from 109.0 ± 33.1 mm2 to 161.1 ± 17.3
mm2 as shown in A. This area in treated animals is starts off at a similar value to that of
the untreated animals, 112.8 ± 12.4 mm2, but increases to 218.9 ± 16.4 mm2 by the end of
8 weeks. This final value is similar to the area of the uninjured side in untreated animals,
218.8 ± 15.2 mm2. The increase in hind paw area with treatment (161.1 ± 17.3 mm2 and
218.9 ± 16.4 mm2; p < .05) indicates that the combination therapy is accelerating
recovery. In Figure 23B though the lines appear to be different at the 8 week time point,
the overall ANOVA was not significant, indicating that there are no differences over time
between the treated and untreated groups. Table 4 displays this data in tabular form.
There is a significant decline in hind paw base of support (BOS) at 2 wpo from
11.1 ± 2.3 mm to 4.6 ± 1.6 mm in untreated animals and 7.2 ± 2.2 mm in treated animals
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*
*

Control
ES+TP
Control
Untreated
Axotomy
ES+TP
Axotomy
Untreated

Figure 22. Effects of brief ES and TP on hind paw width following a
sciatic crush injury. Behavioral testing with the CatWalk™ apparatus was
done to record paw print width during walking after injury. Shown are the
print widths of the injured right hind paw and the contralateral uninjured left
hind paw. Vertical lines represent standard error of the mean. * = p < .05
comparing the treated and untreated animals’ injured paws. n = 6/group.

2 wpo

Control

Axotomy

8 wpo

Control

Axotomy

Untreated

19.4

0.7

11.1

1.0

Untreated

20.3

0.6

16.0

0.8

ES+TP

20.8

0.5

13.6

0.6

ES+TP

20.6

0.3

17.4

0.5

Table 3. Comparison of Hind Paw Width at 2 and 8 wpo after Sciatic Crush Injury. This table highlights the
decrease from week 2 to week 8 in the differences between control and axotomized sides post-sciatic crush.

101

102

A
*
Axotomy
ES+TP
Axotomy
Untreated

B

Control
ES+TP
Control
Untreated

Figure 23. Effects of brief ES and TP on hind paw area following a sciatic
crush injury. Behavioral testing with the CatWalk™ apparatus was done to record
paw prints during walking after injury. Shown are the print areas of the injured
right hind paw (A) and the contralateral uninjured left hind paw (B). Vertical lines
represent standard error of the mean. * = p < .05; n = 6/group.

2 wpo

Control

Axotomy

8 wpo

Control

Axotomy

Untreated

212.0

38.1

109.0

33.1

Untreated

218.8

15.2

161.1

17.3

ES+TP

267.5

19.5

112.8

12.4

ES+TP

282.7

20.1

218.9

16.4

Table 4. Comparison of Hind Paw Area at 2 and 8 wpo after Sciatic Crush Injury. This table highlights the decrease
from week 2 to week 8 in the differences between control and axotomized sides post-sciatic crush.
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104

ES+TP
Untreated

Figure 24. Effects of brief ES and TP on hind paw base of support
following a sciatic crush injury. Behavioral testing with the CatWalk™
apparatus was done to record paw prints during walking after injury. Shown
are the bases of support comparing treated and untreated animals. Vertical
lines represent standard error of the mean. n = 6/group.
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as shown in Figure 24. This is due to the animals putting little to no weight on the
injured paw and drawing it close to their body thus decreasing the BOS; essentially they
are ambulating on three limbs at this early point during the time course. Though there
were no significant differences between the ES+TP-treated and untreated animals over
time; however, there does appear to be a trend towards increased BOS for treated animals
versus untreated animals.
Figure 25 tracks the percentage of footfall patterns that are alternate (Aa and Ab
combined) or are cruciate (Ca and Cb combined). The rotary patterns are rarely used, on
average less than 5% of the time, and this does not change with injury or treatment.
Before injury, the alternate patterns are clearly preferred, being used an average of 66.1 ±
4.9 % of the time. The cruciate patterns are used an average of 32.3 ± 5.2 % of the time.
The change in footfall pattern usage over time for the alternate footfall patterns follows
U-shaped curves; there are inverted U-shaped curves to describe the reciprocal changes in
the use of the cruciate patterns. At 2 and 4 weeks post-operative, both treated and
untreated animals decrease their usage of the alternate patterns and replace them with the
cruciate patterns: % alternate for untreated animals at 2 wpo is 54.5 ± 9.4; % alternate
for treated animals at 2 wpo is 49.5 ± 14.6; % cruciate for untreated animals at 2 wpo is
44.3 ± 10.5; % cruciate for treated animals at 2 wpo is 50.5 ± 14.6; % alternate for
untreated animals at 4 wpo is 52.6 ± 7.5; % alternate for treated animals at 4 wpo is
42.9 ± 8.6; % cruciate for untreated animals at 4 wpo is 45.3 ± 8.5; % cruciate for treated
animals at 4 wpo is 57.1 ± 8.6. At 8 weeks, though, footfall pattern preference has
returned to nearly the same percentages as before injury. Though the differences at 2 and

A
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B

Figure 25. Effects of brief ES and TP on footfall pattern following a sciatic crush
injury. Behavioral testing with the CatWalk™ apparatus was done to record paw
prints during walking after injury. Shown are the percentages of footfall pattern
choices over time of alternate (A) and cruciate (B) patterns. Vertical lines represent
standard error of the mean. n = 6/group.
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4 weeks post-operative were not ultimately significant, this trend to decrease the
percent of alternate patterns and increase the percent of cruciate patterns is interesting.

2.

DIFFERENCES IN FUNCTIONAL RECOVERY FOLLOWING TREATMENT

WITH

ES+TP

COMBINATORIAL

THERAPY

AFTER

SCIATIC

NERVE

AUTOGRAFT
Figure 26 tracks hind paw length over time after injury and the effects of the
combinatorial therapy of ES+TP on this parameter. In contrast to the sciatic crush injury,
in Figure 26A paw length does not change appreciably on the injured side among
untreated animals. The treated animals display a slight increase at 4 wpo, but this is nonsignificant. The uninjured paw increases in length over time from ~23 mm to ~34 mm
similarly in treated and untreated groups.
Figure 27 demonstrates the differences in hind paw width over time due to
treatment with ES+TP. At the 8 and 16 week time points hind paw width is increased in
the injured paw when animals were treated with the combinatorial therapy as compared
to the untreated animals (12.5 ± 1.1 mm, 11.3 ± 1.9 mm, 11.6 ± 1.0, and 10.2 ±1.1,
respectively; p < .05). The combination treatment also stabilized the uninjured paw
width over time. At 2, 4, and 8 weeks post-operative the animals’ uninjured paws are
significantly narrower when untreated than the treated animals’ uninjured paws and take
up to 16 weeks to reach that level (2 wpo: 19.4 ± 0.8 and 21.9 ± 0.5; 4 wpo: 18.8 ± 1.6
and 21.3 ± 0.7; 8 wpo: 19.9 ± 0.7 and 22.6 ± 0.9; p < .05 comparing treatment versus no
treatment).
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A

Axotomy
ES+TP
Axotomy
Untreated

B

Control
ES+TP
Control
Untreated

Figure 26. Effects of brief ES and TP on hind paw length
following autograft.
Behavioral testing with the CatWalk™
apparatus was done to record paw print length during walking after
injury. Shown are the print lengths of the injured right hind paw (A)
and the contralateral uninjured left hind paw (B). Vertical lines
represent standard error of the mean. n = 5/group.
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#

#

#

*

*

Control
ES+TP
Control
Untreated
Axotomy
ES+TP
Axotomy
Untreated

Figure 27. Effects of brief ES and TP on hind paw width following autograft.
Behavioral testing with the CatWalk™ apparatus was done to record paw print width
during walking after injury. Shown are the print widths of the injured right hind paw
and the contralateral uninjured left hind paw. Vertical lines represent standard error
of the mean. # = p < .05, comparing the uninjured left paw of untreated and treated
animals. * = p < .05, comparing the injured right paw of untreated and treated
animals. n = 5/group.
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Figure 28 shows the effects of the combination therapy on recovery of hind
paw area. The combinatorial treatment significantly accelerated the increase in the area
of the injured hind paw as compared to no treatment (4 wpo: 81.5 ± 16.9 mm2 and 48.0 ±
7.3 mm2, respectively; p < .05) as well as that of the uninjured hind paw (2 wpo: 172.2 ±
6.6 mm2 and 221.2 ± 13.4 mm2, respectively; 4 wpo: 181.3 ± 31.4 mm2 and 248.2 ± 23.2
mm2; p < .05 comparing treated to untreated animals). The area occupied by both left
and right hind paws steadily increases over time (8 wpo data is shown in Table 5). In
combination these indicate that both the calf muscles and intrinsic foot muscles are being
reinnervated faster with treatment.

Additionally, the combinatorial treatment also

significantly accelerated the return of base of support as compared to no treatment (4.4 ±
0.9 mm and 9.9 ± 2.3 mm, respectively;

p < .05; Figure 29). Treatment with ES+TP

improved the base of support in animals receiving the autograft injury to nearly the same
levels achieved by the crush injury level at 4 wpo (see Table 6); this is a substantial
improvement considering that the autograft injury is much more severe.
Though the regularity index did not decrease significantly following the sciatic
crush injury, there was a decline in this parameter following the autograft injury from the
baseline value of 97.5 ± 0.6 % to 84.4 ± 3.4 % in untreated animals by the end of the
study (Figure 30). Treatment with the ES+TP combination seemed to stall this decline,
though the differences between treated and untreated animals were ultimately nonsignificant. Also in contrast to the crush injury, the footfall pattern preference did not
seem to be altered immediately following the autograft injury, nor were there changes
over time.
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#

#

Axotomy
ES+TP
Axotomy
Untreated

*

Control
ES+TP
Control
Untreated

Figure 28. Effects of brief ES and TP on hind paw area following autograft.
Behavioral testing with the CatWalk™ apparatus was done to record paw prints
during walking after injury. Shown are the print areas of the injured right hind paw
and the contralateral uninjured left hind paw. Vertical lines represent standard error
of the mean. # = p < .05, comparing the uninjured left paw of untreated and treated
animals. * = p < .05, comparing the injured right paw of untreated and treated
animals. n = 5/group.

8 wpo

Crush

Autograft

Control

Axotomy

Control

Axotomy

Untreated

218.8 15.2

161.1 17.3

240.3 22.3

73.0 15.3

ES+TP

282.7 20.1

218.9 16.4

256.6 24.2

88.0 8.9

Table 5. Comparison of Hind Paw Area at 8 wpo between Sciatic Crush and Autograft Injuries. This table highlights
the differences in hind paw area between the different injuries by week 8 and their responses to treatment with ES+TP.
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113

ES+TP
*
Untreated

Figure 29. Effects of brief ES and TP on hind paw base of support
following autograft. Behavioral testing with the CatWalk™ apparatus was
done to record paw prints during walking after injury. Shown are the bases of
support comparing treated and untreated animals. Vertical lines represent
standard error of the mean. * = p < .05, comparing untreated and treated animals
at a particular time point. n = 5/group.

4 wpo

Crush

Autograft

Untreated

8.7 1.6

4.4 0.9

ES+TP

10.0 3.1

9.9

2.3

Table 6. Comparison of Base of Support at 4 wpo in Crush versus Autograft Injury. This table highlights the
differences in base of support between the different injuries by week 4 and their responses to treatment with ES+TP.
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ES+TP
Untreated

0

Figure 30. Effects of brief ES and TP on regularity index following autograft.
Behavioral testing with the CatWalk™ apparatus was done to record paw prints during
walking after injury. Shown is the regularity index over time in treated and untreated
animals. Vertical lines represent standard error of the mean. n = 5/group.

A

116

B

Figure 31. Effects of brief ES and TP on footfall pattern following autograft.
Behavioral testing with the CatWalk™ apparatus was done to record paw prints during
walking after injury. Shown are the percentages of footfall pattern choices over time of
alternate (A) and cruciate (B) patterns. Vertical lines represent standard error of the
mean. n = 6/group.
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Figure 31 demonstrates the steady preference for the alternate step sequence pattern
~65% of the time and use of the cruciate step pattern ~35% of the time following
autograft; this is unchanged with treatment.

E. DISCUSSION
Sciatic nerve paralysis is a common peripheral nerve injury that has significant
functional impact on patients.

Despite this, there are few available treatments for

traumatic injury to the nerve and none are reliably effective in yielding functional
success. The individual therapies of ES and TP have resulted in improvements but have
not yet been combined (Alrashdan et al., 2010; Brown et al., 1999; Kujawa et al., 1993;
Vivo et al., 2008; Walker et al., 1994). The current study found that administration of the
combination of the two lead to significant improvements in some measures of functional
recovery but not others and these varied depending on injury type.
The parameters hind paw width and hind paw area were both significantly
improved by the combination treatment in both types of injury, indicating that they are
useful functional recovery correlates to rely on in future studies. Since increasing paw
width is correlated with reinnervation of the intrinsic foot muscles, the results suggest
that regeneration of these axons is accelerated by the combinatorial treatment.
Concomitantly, increases in paw length can be correlated to calf muscle reinnervation
(Brown et al, 1999; de Medinaceli et al., 1982). Paw area is a composite parameter and
thus encompasses the length and width parameters; hence, the accelerated recovery that
occurs with treatment indicates that both are being positively affected by the combination
of ES and TP. Even though there was only a trend towards accelerated recovery of print
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length in the crush injury, the increased foot print area engendered by the ES+TP
treatment combined with this trend have positive implications for its treatment potential.
Additionally, since this combination appears to stabilize the print width of the uninjured
foot, while accelerating the return of this parameter on the injured side in the more severe
autograft injury, it suggests that the therapy is enhancing the function of the normal hind
limb to promote balance during the regeneration process. That this is occurring in the
more severe injury paradigm is encouraging for the combination’s potential in human
axonal injury.
As mentioned previously, sciatic injury causes an initial decrease in the hind paw
base of support because the injured paw cannot be used to bear weight and is thus
retracted in towards the belly with gradual increases in the parameter being observed over
time (Deumens et al., 2007). The combination of ES and TP significantly accelerated the
return of this function in the autografted animals, providing further optimism for
incorporating this treatment strategy into existing therapy regimens.
Interestingly enough, step pattern preference and regularity index differed
throughout the course of the experiment between the two different injuries studied:
among the crush-injured animals there was a trend toward a shift from clearly preferring
the alternate patterns prior to injury (2:1 choice of alternate patterns) to ambivalence (1:1
choice of alternate versus cruciate) at 2 and 4 weeks post-operative and a return to the
before-injury preference at 8 weeks post-operative. This could be a sort of protecting
phenomenon, in which the animal favors the injured limb and takes measures to protect it
from further injury, thus allowing it to heal faster. The cruciate patterns provide more
stability to the animal as both paws of the shoulder girdle are in contact with the ground
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before the hind paws have to support any weight; it aids in balancing the animal’s
center of gravity more towards midline. Utilizing these patterns may allow for undivided
focus on repair by the neurons as opposed to splitting efforts between repair and
generating unanswered action potentials. There was no such shift in the animals that had
undergone an autograft. Adding ES+TP to the crush-injured animals further shifted their
preference towards the cruciate step patterns. It is possible that the more time the animal
spends ambulating by cruciate step patterns, the more unfettered time the neuronal cell
bodies have to generate the necessary components to regrow their axons, resulting in
accelerated functional recovery (corroborated by the trend towards maintance of the
regularity index with treatment).
Though the results of this study of the combination treatment of electrical
stimulation and testosterone imply that it has utility in the human population, it is not a
panacea for nerve injury be it axonotmesis nor neurotmesis.

The importance of a

combinatorial strategy cannot be overemphasized, however. Sharma et al., previously
demonstrated the benefit of this combinatorial strategy (2010a). It is likely that for
severe traumatic nerve injury cases, a variety of therapies will need to be applied to
achieve maximal recovery.

CHAPTER VII
SUMMARY, CONCLUSIONS, AND FUTURE DIRECTIONS

A. SUMMARY
This dissertation investigated the effects of the ES plus TP combination therapy
on peripheral nerve injury by studying the functional effects of treatment in three distinct,
clinically relevant, peripheral nerves: the facial nerve, the recurrent laryngeal nerve, and
the sciatic nerve. Aim 1 examined the effects of the combination therapy consisting of
ES and TP in an intracranial facial nerve crush injury model, a model with limited
spontaneous recovery potential. The results are summarized as follows: administration of
the combination of ES and TP improved recovery of facial functional parameters as
compared to no treatment; however, these improvements were only seen in parameters
signifying partial function. Complete recovery was not achieved within the study time
frame by any of the animals, with or without treatment. Aim 2 assessed the effects of ES
and TP in a recurrent laryngeal nerve crush injury model, a model with robust
spontaneous recovery potential. The results determined that administration of ES and TP
had similar effects on functional recovery following a recurrent laryngeal crush as both
treatments individually accelerated the return of vocal fold mobility; however, the
combination of the two therapies did not provide any added benefit beyond the individual
treatments. Aim 3 investigated the effects of the combination therapy including ES
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and TP in two parallel models of sciatic nerve injury: sciatic nerve crush and sciatic
nerve autograft. The results of aim 3 indicated that sciatic nerve crush injury altered the
step pattern choice in rats, whereas a sciatic nerve autograft did not appear to influence
step pattern. Functional recovery did not return to normal in untreated animals by the end
of the study period of 8 wpo (crush) and 16 wpo (autograft); however, treatment with ES
and TP improved functional recovery following both types of sciatic injuries.

B. CONCLUSIONS AND FUTURE DIRECTIONS
The overall results of the present study, as described above, have been presented
and discussed in the corresponding chapters. The following topics now incorporate the
results together in context of current peripheral nerve regeneration research.

1. INSIGHT INTO EXTENT OF ES+TP-MEDIATED THERAPEUTIC EFFECTS IN
THE DIFFERENT PERIPHERAL NERVE INJURY MODELS
The experiments in the present investigation examined the broad efficacy of a
novel combinatorial treatment strategy based on the underlying hypothesis that if the two
treatments, ES and TP, work through different mechanisms, then together they might be
used to obtain additive effects on regeneration. Previous studies have shown that this
combination effectively accelerates recovery after both extratemporal and intratemporal
facial nerve injuries (Hetzler et al., 2008; Sharma et al., 2010a).
The nerve injury site is a reliable factor for predicting recovery, as the more
proximal the injury site is to the cell body, the more prolonged the recovery timeline.
Crushing the facial nerve intracranially is the most proximal peripheral nerve crush injury
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that has been studied to date; this injury shares similarities with ventral root avulsion
in the spinal cord except no CNS trauma occurs with intracranial facial nerve crush.
Applying the combination therapy to this severely proximal injury yields benefit, but not
as striking as that seen in the intratemporal facial nerve crush model. This finding
suggests that other therapies may need to be added to the ES+TP combination to achieve
better recovery outcomes in the future. In contrast, the RLN is typically injured rather
distal to the cell body, and as such spontaneous recovery is always exhibited in animal
models. The application of the individual therapies appears to be sufficient to boost
regeneration measurably by decreasing the time required to achieve complete functional
recovery. This phenomenon may be advantageous for this particular nerve, as it is can be
injured during cardiovascular surgeries, thyroidectomies, and anterior approaches to the
cervical spine. In situations where TP administration would be contraindicated, such as
pregnancy or prostate cancer, to have a potential treatment that works well enough on its
own is promising. Unlike the RLN crush but similar to the proximal intracranial facial
nerve injury, sciatic nerve injuries follow a protracted recovery timeline. The functional
improvements seen following both sciatic nerve injuries indicate that though the
combination therapy of ES and TP is helpful, there is still much work to be done in
finding effective treatments for peripheral nerve injury.

2. INSIGHT INTO OTHER TREATMENTS THAT MAY BE COMBINED WITH ES
AND TP
Prior research has demonstrated that ES mediates its positive effects by directly
affecting the motoneuron cell body (Al-Majed et al., 2000a) to rapidly enhance the
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expression of various regeneration-associated genes (Sharma et al., 2010b) which
results in a decreased delay to sprout formation (Sharma et al., 2009b). Activation of
neurotrophin signaling is most likely an important result of ES treatment and precedes
upregulation of cytoskeletal proteins (Al-Majed et al., 2000b; Al-Majed et al., 2004).
Another important source of neurotrophic factors are denervated Schwann cells and the
distal nerve stumps; yet, the upregulation of BDNF and GDNF at these sites is delayed
after axotomy (Hoke et al., 2006; Boyd and Gordon, 2003a; Boyd and Gordon, 2003b).
The delayed availability of neurotrophic factors from these sources suggests that the
neuronal source is of critical importance during earlier times of axonal outgrowth;
furthermore, ES is likely enhancing regeneration via the immediate upregulation of
neurotrophic molecules.
Previous studies have established that the androgen-induced augmentation of
facial nerve regeneration is AR-dependent. Administration of flutamide, a potent AR
blocker that prevents binding of TP, prevents the TP-induced increase in regeneration
rate (Kujawa et al., 1995).

Interestingly, axonal injury results in significant

downregulation of AR in the FMN and Spinal Nucleus of the Bulbocavernosus models
(Drengler et al., 1997; Lubischer and Arnold, 1995). Injury may induce transcription of
cytoskeletal and growth-associated genes and shut down production of other less
important genes such as AR. Therefore, TP may mediate a more long term effect by
increasing the regeneration rate through the mobilization of preexisting steroid receptors.
Though the molecular regeneration program is important, other aspects of the
regeneration process need to be explored to maximize the recovery potential. Electrical
stimulation of the target musculature (transcutaneous and subcutaneous) has been
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explored in humans after certain nerve injuries. Transcutaneous electrical nerve
stimulation (TENS), though used more for pain relief due to its activation of the
endorphins, enkephalins, and dynorphins (Solomon et al., 1980; Bushnell et al., 1991;
Han et al., 1991), may have positive effects on motoneurons.

Additionally, the

application of a therapy that modulates pain sensitivity may indirectly affect motor
function by removing the negative effect that pain has on voluntary movement.
Subcutaneous stimulation of the target musculature may also keep it viable for longer,
enhancing its potential for reinnervation. Voluntary movement in the form of exercise, as
well as forced exercise, has been shown to improve functional recovery from traumatic
peripheral nerve injury as well as spinal cord injury.

This is thought to occur via

increasing neurotrophin levels in the CNS near the neuronal cell bodies and altering the
expression patterns of apoptosis-associated microRNAs following injury (English et al.,
2011; Côté et al, 2011; Liu et al., 2010). Exercise and other vigorous forms of physical
therapy may provide a bridge to further extending axonal regeneration to promote
improved functional recovery outcomes. These therapies may aid the combination of ES
and TP in accelerating regeneration and supporting recovery.

3. BENEFITS OF A COMBINATORIAL TREATMENT APPROACH
The need for combinatorial treatments is especially evident as neither ES nor TP
alone are effective in improving complete functional recovery in rats following an
intratemporal injury of the facial nerve (Sharma et al., 2010a). In addition, the current
investigation demonstrated that this combination does not accelerate regeneration enough
to achieve complete functional recovery in the intracranial crush injury within the time
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limit of the experiment. The finding that the combinatorial treatment of ES plus TP
substantially shortens the time to recover partial function may be due to ES recruiting
more motoneurons to cross the crush zone early, while TP maintains neurotrophic factor
and growth-associated gene expression to potentially promote target reinnervation. TP
may also avert the muscle atrophy associated with prolonged target denervation. As ES
has previously been reported to increase specificity of reinnervation and direct Schwann
cell polarity, brief ES treatment may enhance the outcome of intracranial facial nerve
injury by reducing deviant regeneration along the multiple branches of the motor nerve
and steering axons in the correct direction. Therefore, a combinatorial treatment strategy
would be especially beneficial in cases of prolonged recovery periods following nerve
injury and attaching extra treatments that target other obstacles in the regeneration
process would be additionally advantageous.

4. THERAPEUTIC NEED AND POTENTIAL FOR TRANSLATION OF THE ES+TP
TREATMENT STRATEGY
Regeneration in humans is known to be at least 2 times slower in comparison to
animal models of peripheral nerve regeneration (Gordon et al., 2008). Given the ~4
mm/d regeneration rate for the fastest growing axons in rats (Kujawa et al., 1993; Wang
et al., 1997), the expected regeneration rate in humans would be ~1.7 mm/d, reported by
Sunderland in 1947. Furthermore, the latency period for axons to traverse the injury site
and enter distal nerve stumps is also longer in humans. In addition to an inherently
slower regeneration rate, peripheral nerves in humans also have to regenerate over
considerably longer distances post-injury as compared to rats. Therefore, suboptimal
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functional recovery is often seen following peripheral nerve injuries. The past quarter
of a century has focused on optimization of surgical repair of injured nerves, neglecting
the opportunity to simultaneously target the molecular mechanisms of regeneration.
As ES and TP differentially enhance the intrinsic ability of neurons to regenerate,
together they are an effective treatment strategy prospect. Several studies demonstrate
successful translation of ES and TP treatments individually into the clinic. Brief ES of
the median nerve in carpal tunnel syndrome patients has been shown to improve recovery
of thenar function (Gordon et al., 2007). Direct ES of the sacral and hypoglossal nerves
have also been conducted in patient trials for treatment of bladder dysfunction and
obstructive sleep apnea, respectively (Sutherland et al., 2007; Schwartz et al., 2001).
Therefore, ES, for a brief duration, represents a feasible approach as a treatment for
peripheral nerve injuries especially when a nerve is injured throughout the course of a
surgical procedure such as the RLN injury. Similarly, testosterone treatment has been
tested in multiple patient trials. Intramuscular testosterone treatment in men diagnosed
with Parkinson’s disease increased total testosterone levels by ~270% and improved nonmotor symptoms of the disease (Okun et al., 2006; Okun et al., 2002). Sublingual
administration of testosterone in healthy females also attenuates the integrated central
stress response (Hermans et al., 2007). Clinical trials in male multiple sclerosis patients
have demonstrated that application of testosterone gel to the upper arms increased
circulating hormone levels by an average of 50% and improved cognitive function,
slowed brain atrophy rate, and induced production of neurotrophic factors (Sicotte et al.,
2002; Gold et al., 2008). Testosterone replacement therapy has also been successful in
increasing muscle mass in AIDS patients with wasting (Sardar et al., 2010).
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The application of testosterone treatment to human peripheral nerve injuries
has not yet been attempted. As different doses and routes of delivery for testosterone
treatment are currently being used in patient trials for other maladies, the most effective
dosage and administration method would have to be determined for the various peripheral
nerve injuries. Our studies have shown that supraphysiological levels (>3 times normal
levels) are required for the effect of enhanced regeneration. Previous studies from our
lab have demonstrated that following an extratemporal facial nerve crush in male
hamsters, TP needs to be administered within 6 h of injury for a period of 6 h in order to
have beneficial effects (Tanzer and Jones, 2004). Furthermore, a 6 h immediate TP
exposure enhanced regeneration and functional recovery to the same extent as a 7 d
treatment.

These findings have important clinical implications and suggest that an

immediate but short-term treatment with gonadal steroids may have significant
therapeutic advantages for peripheral nerve injuries.

SIGNIFICANCE
In conclusion, the combination of ES and TP can be applied broadly to a variety
of traumatic peripheral nerve injuries. Though the improvements seen in the models
studied in this dissertation were varied, ranging from progress in partial recovery to
accelerating the return of complete functional recovery, the overarching theme is that
increases in function occurred in all of the nerve injury models following treatment with
ES+TP. The treatments were effective in all four injury paradigms, indicating that the
positive effects of ES+TP are not limited to injuries of the facial nerve, nor are they
specific to cranial nerves.

Thus, scientists and physicians should transition to
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investigating this combination treatment in humans with traumatic peripheral nerve
injuries.
The present study offers insight into the general effects of ES and TP on
functional recovery in four peripheral nerve injury models. However, several questions
remain to be elucidated and thus are presented as future directions below.

These

additional studies will further advance the translation of the proposed combinatorial
treatment strategy (ES plus TP) into the clinic. These questions are as follows: what is
the minimal dose and duration of TP treatment required to achieve therapeutic effects? Is
there increased cell loss from the intracranial facial nerve crush injury that can explain
the substantially delayed timeline for functional recovery in untreated animals? Does the
combination of ES+TP rescue any cell loss in this model if it occurs? Finally, can other
therapies, such as exercise and target muscle stimulation, further enhance recovery seen
in the peripheral nerve injury models with prolonged recovery periods, the intracranial
facial nerve crush, the sciatic nerve crush, and the sciatic nerve autograft?
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